115 results on '"Boumis E."'
Search Results
2. The Epidemiology of Recurrent Bacterial Pneumonia in People with AIDS in Europe
- Author
-
Puro, V., Serraino, D., Piselli, P., Boumis, E., Petrosillo, N., Angeletti, C., and Ippolito, G.
- Published
- 2005
3. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
- Author
-
Campoli, C., Siccardi, G., Ambretti, S., Stallmach, A., Venditti, M., Lucidi, C., Ludovisi, S., De Cueto, M., Navarro, M.D., Lopez Cortes, E., Bouza, E., Valerio, M., Eworo, A., Losito, R., Senzolo, M., Nadal, E., Ottobrelli, A., Varguvic, M., Badia, C., Borgia, G., Gentile, I., Buonomo, A.R., Boumis, E., Beteta-Lopez, A., Rianda, A., Taliani, G., Grieco, S., Bartoletti, M., Giannella, M., Lewis, R., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M., Cobos-Trigueros, N., Seminari, E., Retamar, P., Muñoz, P., Tumbarello, M., Burra, P., Torrani Cerenzia, M., Barsic, B., Calbo, E., Maraolo, A.E., Petrosillo, N., Galan-Ladero, M.A., D'Offizi, G., Bar Sinai, N., Rodríguez-Baño, J., Verucchi, G., Bernardi, M., and Viale, P.
- Published
- 2018
- Full Text
- View/download PDF
4. Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
- Author
-
Vergori, A., Lorenzini, P., Cozzi-Lepri, A., Donno, D. R., Gualano, G., Nicastri, E., Iacomi, F., Marchioni, L., Campioni, P., Schinina, V., Cicalini, S., Agrati, C., Capobianchi, M. R., Girardi, E., Ippolito, G., Vaia, F., Petrosillo, N., Antinori, A., Taglietti, F., The ReCOVeRI Study Group: Abbonizio, M. A., Abdeddaim, A., Agostini, E., Albarello, F., Amadei, G., Amendola, A., Antonica, M. A., Antonini, M., Bartoli, T. A., Baldini, F., Barbaro, R., Bartolini, B., Bellagamba, R., Benigni, M., Bevilacqua, N., Biava, G., Bibas, M., Bordi, L., Bordoni, V., Boumis, E., Branca, M., Buonomo, R., Busso, D., Camici, M., Canichella, F., Capone, A., Caporale, C., Caraffa, E., Caravella, I., Carletti, F., Castilletti, C., Cataldo, A., Cerilli, S., Cerva, C., Chiappini, R., Chinello, P., Cianfarani, M. A., Ciaralli, C., Cimaglia, C., Cinicola, N., Ciotti, V., Colavita, F., Corpolongo, A., Cristofaro, M., Curiale, S., D'Abramo, A., Dantimi, C., De Angelis, A., De Angelis, G., De Palo, M. G., De Zottis, F., Di Bari, V., Di Lorenzo, R., Di Stefano, F., D'Offizi, G., Evangelista, F., Faraglia, F., Farina, A., Ferraro, F., Fiorentini, L., Frustaci, A., Fusetti, M., Fusto, M., Galati, V., Gagliardini, R., Galli, P., Garotto, G., Gaviano, I., Tekle, S. G., Giancola, M. L., Giansante, F., Giombini, E., Granata, G., Greci, M. C., Grilli, E., Grisetti, S., Iaconi, M., Iannicelli, G., Inversi, C., Lalle, E., Lamanna, M. E., Lanini, S., Lapa, D., Lepore, L., Libertone, R., Lionetti, R., Liuzzi, G., Loiacono, L., Lucia, A., Lufrani, F., Macchione, M., Maffongelli, G., Marani, A., Mariano, A., Marini, M. C., Maritti, M., Mastrobattista, A., Mastrorosa, I., Matusali, G., Mazzotta, V., Mencarini, P., Meschi, S., Messina, F., Micarelli, S., Mogavero, G., Mondi, A., Montalbano, M., Montaldo, C., Mosti, S., Murachelli, S., Musso, M., Nardi, M., Navarra, A., Nocioni, M., Noto, P., Noto, R., Oliva, A., Onnis, I., Ottou, S., Palazzolo, C., Pallini, E., Palmieri, F., Palombi, G., Pareo, C., Passeri, V., Pelliccioni, F., Penna, G., Petrecchia, A., Petrone, A., Pianura, E., Pinnetti, C., Pisciotta, M., Piselli, P., Pittalis, S., Pontarelli, A., Proietti, C., Puro, V., Ramazzini, P. M., Rianda, A., Rinonapoli, G., Rosati, S., Rubino, D., Rueca, M., Ruggeri, A., Sacchi, A., Sampaolesi, A., Sanasi, F., Santagata, C., Scarabello, A., Scarcia, S., Scognamiglio, P., Scorzolini, L., Stazi, G., Strano, G., Taibi, C., Taloni, G., Nardi, T., Tonnarini, R., Topino, S., Tozzi, M., Vairo, F., Valli, M. B., Vincenzi, L., Visco-Comandini, U., Vita, S., Vittozzi, P., Zaccarelli, M., Zanetti, A., Zito, S., Vergori, A., Lorenzini, P., Cozzi-Lepri, A., Donno, D. R., Gualano, G., Nicastri, E., Iacomi, F., Marchioni, L., Campioni, P., Schinina, V., Cicalini, S., Agrati, C., Capobianchi, M. R., Girardi, E., Ippolito, G., Vaia, F., Petrosillo, N., Antinori, A., Taglietti, F., Abbonizio, M. A., Abdeddaim, A., Agostini, E., Albarello, F., Amadei, G., Amendola, A., Antonica, M. A., Antonini, M., Bartoli, T. A., Baldini, F., Barbaro, R., Bartolini, B., Bellagamba, R., Benigni, M., Bevilacqua, N., Biava, G., Bibas, M., Bordi, L., Bordoni, V., Boumis, E., Branca, M., Buonomo, R., Busso, D., Camici, M., Canichella, F., Capone, A., Caporale, C., Caraffa, E., Caravella, I., Carletti, F., Castilletti, C., Cataldo, A., Cerilli, S., Cerva, C., Chiappini, R., Chinello, P., Cianfarani, M. A., Ciaralli, C., Cimaglia, C., Cinicola, N., Ciotti, V., Colavita, F., Corpolongo, A., Cristofaro, M., Curiale, S., D'Abramo, A., Dantimi, C., De Angelis, A., De Angelis, G., De Palo, M. G., De Zottis, F., Di Bari, V., Di Lorenzo, R., Di Stefano, F., D'Offizi, G., Evangelista, F., Faraglia, F., Farina, A., Ferraro, F., Fiorentini, L., Frustaci, A., Fusetti, M., Fusto, M., Galati, V., Gagliardini, R., Galli, P., Garotto, G., Gaviano, I., Tekle, S. G., Giancola, M. L., Giansante, F., Giombini, E., Granata, G., Greci, M. C., Grilli, E., Grisetti, S., Iaconi, M., Iannicelli, G., Inversi, C., Lalle, E., Lamanna, M. E., Lanini, S., Lapa, D., Lepore, L., Libertone, R., Lionetti, R., Liuzzi, G., Loiacono, L., Lucia, A., Lufrani, F., Macchione, M., Maffongelli, G., Marani, A., Mariano, A., Marini, M. C., Maritti, M., Mastrobattista, A., Mastrorosa, I., Matusali, G., Mazzotta, V., Mencarini, P., Meschi, S., Messina, F., Micarelli, S., Mogavero, G., Mondi, A., Montalbano, M., Montaldo, C., Mosti, S., Murachelli, S., Musso, M., Nardi, M., Navarra, A., Nocioni, M., Noto, P., Noto, R., Oliva, A., Onnis, I., Ottou, S., Palazzolo, C., Pallini, E., Palmieri, F., Palombi, G., Pareo, C., Passeri, V., Pelliccioni, F., Penna, G., Petrecchia, A., Petrone, A., Pianura, E., Pinnetti, C., Pisciotta, M., Piselli, P., Pittalis, S., Pontarelli, A., Proietti, C., Puro, V., Ramazzini, P. M., Rianda, A., Rinonapoli, G., Rosati, S., Rubino, D., Rueca, M., Ruggeri, A., Sacchi, A., Sampaolesi, A., Sanasi, F., Santagata, C., Scarabello, A., Scarcia, S., Scognamiglio, P., Scorzolini, L., Stazi, G., Strano, G., Taibi, C., Taloni, G., Nardi, T., Tonnarini, R., Topino, S., Tozzi, M., Vairo, F., Valli, M. B., Vincenzi, L., Visco-Comandini, U., Vita, S., Vittozzi, P., Zaccarelli, M., Zanetti, A., and Zito, S.
- Subjects
Male ,medicine.medical_treatment ,Rome ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Severity of Illness Index ,0302 clinical medicine ,Retrospective Studie ,Coagulopathy ,Clinical endpoint ,Intubation ,Respiratory function ,030212 general & internal medicine ,Multidisciplinary ,Middle Aged ,Medicine ,Female ,Human ,medicine.medical_specialty ,Patients ,medicine.drug_class ,Science ,Low molecular weight heparin ,Risk Assessment ,Article ,NO ,03 medical and health sciences ,Internal medicine ,Severity of illness ,medicine ,Intubation, Intratracheal ,Humans ,Retrospective Studies ,Aged ,business.industry ,SARS-CoV-2 ,COVID-19 ,Thrombocytopenia ,Retrospective cohort study ,Heparin, Low-Molecular-Weight ,medicine.disease ,Respiration, Artificial ,COVID-19 Drug Treatment ,respiratory tract diseases ,Pneumonia ,Viral infection ,business - Abstract
Prophylactic low molecular weight heparin (pLMWH) is currently recommended in COVID-19 to reduce the risk of coagulopathy. The aim of this study was to evaluate whether the antinflammatory effects of pLMWH could translate in lower rate of clinical progression in patients with COVID-19 pneumonia. Patients admitted to a COVID-hospital in Rome with SARS-CoV-2 infection and mild/moderate pneumonia were retrospectively evaluated. The primary endpoint was the time from hospital admission to orotracheal intubation/death (OTI/death). A total of 449 patients were included: 39% female, median age 63 (IQR, 50–77) years. The estimated probability of OTI/death for patients receiving pLMWH was: 9.5% (95% CI 3.2–26.4) by day 20 in those not receiving pLMWH vs. 10.4% (6.7–15.9) in those exposed to pLMWH; p-value = 0.144. This risk associated with the use of pLMWH appeared to vary by PaO2/FiO2 ratio: aHR 1.40 (95% CI 0.51–3.79) for patients with an admission PaO2/FiO2 ≤ 300 mmHg and 0.27 (0.03–2.18) for those with PaO2/FiO2 > 300 mmHg; p-value at interaction test 0.16. pLMWH does not seem to reduce the risk of OTI/death mild/moderate COVID-19 pneumonia, especially when respiratory function had already significantly deteriorated. Data from clinical trials comparing the effect of prophylactic vs. therapeutic dosage of LMWH at various stages of COVID-19 disease are needed.
- Published
- 2021
5. Synergy between vitamin D and sex hormones in respiratory functionality of patients affected by COVID-19
- Author
-
Peruzzu, D., Pagano, M. T., Pierdominici, M., Ruggieri, A., Antinori, A., D'Offizi, G., Petrosillo, N., Palmieri, F., Piselli, P., Boumis, E., Notari, S., Nicastri, E., Agrati, C., Ippolito, G., Gagliardi, M. C., Capobianchi, M. R., Ortona, E., Anticoli, S., Bellenghi, M., Bordoni, V., Camici1, M., Casetti, R., Cerva, C., Chinello, P., Imini, E., Donno, D. R., Dupuis, M. L., Faraglia, F., Fecchi, K., Gagliardini, R., Grassi, G., Di Lorenzo, R., Macchione, M., Maffongelli, G., Mattia, G., Milozzi, E., Pontecorvi, G., Puglisi, R., Sacchi, A., Tartaglia, E., and Vita, S.
- Subjects
0301 basic medicine ,sex differences ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Population ,Physiology ,vitamin D ,RM1-950 ,sex hormones ,03 medical and health sciences ,0302 clinical medicine ,Epidemiology ,Vitamin D and neurology ,gender ,Medicine ,Pharmacology (medical) ,Respiratory system ,education ,Testosterone ,Pharmacology ,education.field_of_study ,030219 obstetrics & reproductive medicine ,business.industry ,SARS-CoV-2 ,Plasma levels ,030104 developmental biology ,Perspective ,Therapeutics. Pharmacology ,business ,Hormone - Abstract
The outcome of COVID-19 appears to be influenced by vitamin D status of population. Although epidemiological data indicate that COVID-19 produces more severe symptoms and higher mortality in elderly in comparison to young patients and in men in comparison to women to date sex and age differences in vitamin D status in infected patients have not been evaluated yet. In this study we evaluated the levels of circulating 25(OH)D in patients hospitalized for COVID-19 divided accordingly to their sex and age. We also correlated 25(OH)D levels with patient’s respiratory status (i.e., PaO2/FiO2 ratio) and with sex hormones plasma levels to analyze the potential relationship of these parameters. We found no significant differences in plasma levels of 25(OH)D between pre- and post-menopausal female patients and age matched male patients. Interestingly, the 25(OH)D plasma levels positively correlated to PaO2/FiO2 ratio only in young patients, regardless of their sex. We also found a significantly positive correlation between 17β-estradiol and 25(OH)D in elderly women and between testosterone and 25(OH)D in elderly men, supporting the role of sex hormones in maintaining 25(OH)D levels. In conclusion, we suggest that a synergy between vitamin D and sex hormones could contribute to the age-related outcome of COVID-19.
- Published
- 2021
6. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
- Author
-
Fabbiani, M, Gagliardini, R, Ciccarelli, N, Roldan, E, Latini, A, D'Ettorre, G, Antinori, A, Castagna, A, Orofino, G, Francisci, D, Chinello, P, Madeddu, G, Grima, P, Rusconi, S, Del Pin, B, Lombardi, F, D'Avino, A, Foca, E, Colafigli, M, Cauda, R, Di Giambenedetto, S, De Luca, A, Mondi, A, Borghetti, A, Baldonero, E, Belmonti, S, Lamonica, S, Sidella, L, Tamburrini, E, Visconti, E, Giacometti, A, Barchiesi, F, Castelli, P, Cirioni, O, Mazzocato, S, Di Pietro, M, Blanc, P, Degli Esposti, A, Mariabelli, E, Marini, S, Poggi, A, Quiros Roldan, E, Amadasi, S, Apostoli, A, Biasi, L, Bonito, A, Brianese, N, Compostella, S, Ferraresi, A, Motta, D, Mughini, M, Celesia, B, Gussio, M, Sofia, S, Tana, M, Tundo, P, Viscoli, C, De Hoffer, L, Di Biagio, A, Grignolo, S, Parisini, A, Schenone, E, Taramasso, L, Manconi, P, Boccone, A, Ortu, F, Piano, P, Serusi, L, Puoti, M, Moioli, M, Rossotti, R, Travi, G, Ventura, F, Galli, M, Di Nardo Stuppino, S, Di Cristo, V, Giacomelli, A, Vimercati, V, Viale, P, Gori, A, Rizzardini, G, Capetti, A, Carenzi, L, Mazza, F, Meraviglia, P, Rosa, S, Zucchi, P, Mineo, M, Giuliani, M, Pacifici, A, Pimpinelli, F, Solivetti, F, Stivali, F, Angelici, F, Bellagamba, R, Delle Rose, D, Fezza, R, Libertone, R, Mosti, S, Narciso, P, Nicastri, E, Ottou, S, Tomassi, C, Vlassi, C, Zaccarelli, M, Zoppe, F, Vullo, V, Altavilla, F, Ceccarelli, G, Fantauzzi, A, Gebremeskel, S, Lo Menzo, S, Mezzaroma, I, Tierno, F, Petrosillo, N, Boumis, E, Cicalini, S, Grilli, E, Musso, M, Stella, C, Mura, M, Bagella, P, Mannazzu, M, Soddu, V, Caramello, P, Carcieri, C, Carosella, S, Farenga, M, Scotton, P, Rossi, M, Concia, E, Corsini, F, Gricolo, C, Lanzafame, M, Lattuada, E, Leonardi, S, Rigo, F, Lazzarin, A, Bigoloni, A, Carini, E, Nozza, S, Spagnuolo, V, Belfiori, B, Malincarne, L, Schiaroli, E, Sfara, C, Tosti, A, Sacchini, D, Ruggieri, A, Valdatta, C, Fabbiani M., Gagliardini R., Ciccarelli N., Roldan E. Q., Latini A., d'Ettorre G., Antinori A., Castagna A., Orofino G., Francisci D., Chinello P., Madeddu G., Grima P., Rusconi S., Del Pin B., Lombardi F., D'Avino A., Foca E., Colafigli M., Cauda R., Di Giambenedetto S., De Luca A., Mondi A., Borghetti A., Baldonero E., Belmonti S., Lamonica S., Sidella L., Tamburrini E., Visconti E., Giacometti A., Barchiesi F., Castelli P., Cirioni O., Mazzocato S., Di Pietro M., Blanc P., Degli Esposti A., Mariabelli E., Marini S., Poggi A., Quiros Roldan E., Amadasi S., Apostoli A., Biasi L., Bonito A., Brianese N., Compostella S., Ferraresi A., Motta D., Mughini M. T., Celesia B. M., Gussio M., Sofia S., Tana M., Tundo P., Viscoli C., De Hoffer L., Di Biagio A., Grignolo S., Parisini A., Schenone E., Taramasso L., Manconi P. E., Boccone A., Ortu F., Piano P., Serusi L., Puoti M., Moioli M. C., Rossotti R., Travi G., Ventura F., Galli M., Di Nardo Stuppino S., Di Cristo V., Giacomelli A., Vimercati V., Viale P., Gori A., Rizzardini G., Capetti A., Carenzi L., Mazza F., Meraviglia P., Rosa S., Zucchi P., Mineo M., Giuliani M., Pacifici A., Pimpinelli F., Solivetti F., Stivali F., Angelici F., Bellagamba R., Delle Rose D., Fezza R., Libertone R., Mosti S., Narciso P., Nicastri E., Ottou S., Tomassi C., Vlassi C., Zaccarelli M., Zoppe F., Vullo V., Altavilla F., Ceccarelli G., Fantauzzi A., Gebremeskel S., Lo Menzo S., Mezzaroma I., Tierno F., Petrosillo N., Boumis E., Cicalini S., Grilli E., Musso M., Stella C., Mura M. S., Bagella P., Mannazzu M., Soddu V., Caramello P., Carcieri C., Carosella S., Farenga M., Scotton P. G., Rossi M. C., Concia E., Corsini F., Gricolo C., Lanzafame M., Lattuada E., Leonardi S., Rigo F., Lazzarin A., Bigoloni A., Carini E., Nozza S., Spagnuolo V., Belfiori B., Malincarne L., Schiaroli E., Sfara C., Tosti A., Sacchini D., Ruggieri A., Valdatta C., Fabbiani, M, Gagliardini, R, Ciccarelli, N, Roldan, E, Latini, A, D'Ettorre, G, Antinori, A, Castagna, A, Orofino, G, Francisci, D, Chinello, P, Madeddu, G, Grima, P, Rusconi, S, Del Pin, B, Lombardi, F, D'Avino, A, Foca, E, Colafigli, M, Cauda, R, Di Giambenedetto, S, De Luca, A, Mondi, A, Borghetti, A, Baldonero, E, Belmonti, S, Lamonica, S, Sidella, L, Tamburrini, E, Visconti, E, Giacometti, A, Barchiesi, F, Castelli, P, Cirioni, O, Mazzocato, S, Di Pietro, M, Blanc, P, Degli Esposti, A, Mariabelli, E, Marini, S, Poggi, A, Quiros Roldan, E, Amadasi, S, Apostoli, A, Biasi, L, Bonito, A, Brianese, N, Compostella, S, Ferraresi, A, Motta, D, Mughini, M, Celesia, B, Gussio, M, Sofia, S, Tana, M, Tundo, P, Viscoli, C, De Hoffer, L, Di Biagio, A, Grignolo, S, Parisini, A, Schenone, E, Taramasso, L, Manconi, P, Boccone, A, Ortu, F, Piano, P, Serusi, L, Puoti, M, Moioli, M, Rossotti, R, Travi, G, Ventura, F, Galli, M, Di Nardo Stuppino, S, Di Cristo, V, Giacomelli, A, Vimercati, V, Viale, P, Gori, A, Rizzardini, G, Capetti, A, Carenzi, L, Mazza, F, Meraviglia, P, Rosa, S, Zucchi, P, Mineo, M, Giuliani, M, Pacifici, A, Pimpinelli, F, Solivetti, F, Stivali, F, Angelici, F, Bellagamba, R, Delle Rose, D, Fezza, R, Libertone, R, Mosti, S, Narciso, P, Nicastri, E, Ottou, S, Tomassi, C, Vlassi, C, Zaccarelli, M, Zoppe, F, Vullo, V, Altavilla, F, Ceccarelli, G, Fantauzzi, A, Gebremeskel, S, Lo Menzo, S, Mezzaroma, I, Tierno, F, Petrosillo, N, Boumis, E, Cicalini, S, Grilli, E, Musso, M, Stella, C, Mura, M, Bagella, P, Mannazzu, M, Soddu, V, Caramello, P, Carcieri, C, Carosella, S, Farenga, M, Scotton, P, Rossi, M, Concia, E, Corsini, F, Gricolo, C, Lanzafame, M, Lattuada, E, Leonardi, S, Rigo, F, Lazzarin, A, Bigoloni, A, Carini, E, Nozza, S, Spagnuolo, V, Belfiori, B, Malincarne, L, Schiaroli, E, Sfara, C, Tosti, A, Sacchini, D, Ruggieri, A, Valdatta, C, Fabbiani M., Gagliardini R., Ciccarelli N., Roldan E. Q., Latini A., d'Ettorre G., Antinori A., Castagna A., Orofino G., Francisci D., Chinello P., Madeddu G., Grima P., Rusconi S., Del Pin B., Lombardi F., D'Avino A., Foca E., Colafigli M., Cauda R., Di Giambenedetto S., De Luca A., Mondi A., Borghetti A., Baldonero E., Belmonti S., Lamonica S., Sidella L., Tamburrini E., Visconti E., Giacometti A., Barchiesi F., Castelli P., Cirioni O., Mazzocato S., Di Pietro M., Blanc P., Degli Esposti A., Mariabelli E., Marini S., Poggi A., Quiros Roldan E., Amadasi S., Apostoli A., Biasi L., Bonito A., Brianese N., Compostella S., Ferraresi A., Motta D., Mughini M. T., Celesia B. M., Gussio M., Sofia S., Tana M., Tundo P., Viscoli C., De Hoffer L., Di Biagio A., Grignolo S., Parisini A., Schenone E., Taramasso L., Manconi P. E., Boccone A., Ortu F., Piano P., Serusi L., Puoti M., Moioli M. C., Rossotti R., Travi G., Ventura F., Galli M., Di Nardo Stuppino S., Di Cristo V., Giacomelli A., Vimercati V., Viale P., Gori A., Rizzardini G., Capetti A., Carenzi L., Mazza F., Meraviglia P., Rosa S., Zucchi P., Mineo M., Giuliani M., Pacifici A., Pimpinelli F., Solivetti F., Stivali F., Angelici F., Bellagamba R., Delle Rose D., Fezza R., Libertone R., Mosti S., Narciso P., Nicastri E., Ottou S., Tomassi C., Vlassi C., Zaccarelli M., Zoppe F., Vullo V., Altavilla F., Ceccarelli G., Fantauzzi A., Gebremeskel S., Lo Menzo S., Mezzaroma I., Tierno F., Petrosillo N., Boumis E., Cicalini S., Grilli E., Musso M., Stella C., Mura M. S., Bagella P., Mannazzu M., Soddu V., Caramello P., Carcieri C., Carosella S., Farenga M., Scotton P. G., Rossi M. C., Concia E., Corsini F., Gricolo C., Lanzafame M., Lattuada E., Leonardi S., Rigo F., Lazzarin A., Bigoloni A., Carini E., Nozza S., Spagnuolo V., Belfiori B., Malincarne L., Schiaroli E., Sfara C., Tosti A., Sacchini D., Ruggieri A., and Valdatta C.
- Abstract
Objectives: To investigate the long-term safety and efficacy of a treatment switch to dual ART with atazanavir/ritonavir+lamivudine versus continuing a standard regimen with atazanavir/ritonavir+2NRTI in virologically suppressed patients. Methods: ATLAS-M is a 96 week open-label, randomized, non-inferiority (margin -12%) trial enrolling HIV-infected adults on atazanavir/ritonavir+2NRTI, with stable HIV-RNA < 50 copies/mL and CD4 counts.200 cells/mm3. At baseline, patients were randomized 1:1 to switch to atazanavir/ritonavir+lamivudine or to continue the previous regimen. Here, we report the 96 week efficacy and safety data. The study was registered with ClinicalTrials.gov, number NCT01599364. Results: Overall, 266 subjects were enrolled (133 in each arm). At 96 weeks, in the ITT population, patients free of treatment failure totalled 103 (77.4%) with atazanavir/ritonavir+lamivudine and 87 (65.4%) with triple therapy (difference +12.0%, 95% CI +1.2/+22.8, P=0.030), demonstrating the superiority of dual therapy. Two (1.5%) and 9 (6.8%) virological failures occurred in the dual-therapy arm and the triple-therapy arm, respectively, without development of resistance to any study drug. Clinical adverse events occurred at similar rates in both arms. A higher frequency of grade 3-4 hyperbilirubinemia (66.9% versus 50.4%, P=0.006) and hypertriglyceridaemia (6.8% versus 1.5%, P=0.031) occurred with dual therapy, although this never led to treatment discontinuation. A significant improvement in renal function and lumbar spine bone mineral density occurred in the dual-therapy arm. The evolution of CD4, HIV-DNA levels and neurocognitive performance was similar in both arms. Conclusions: In this randomized study, a treatment switch to atazanavir/ritonavir+lamivudine was superior over the continuation of atazanavir/ritonavir+2NRTI in virologically suppressed patients, with a sustained benefit in terms of improved renal function and bone mineral density.
- Published
- 2018
7. On Behalf Of Inmi ReCOVeRI Study Group. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay
- Author
-
Bordi L, Sberna G, Lalle E, Piselli P, Colavita F, Nicastri E, Antinori A, Boumis E, Petrosillo N, Marchioni L, Minnucci G, D'Agostini E, Castilletti C, Locatelli F, Zumla A, Ippolito G, Capobianchi MR
- Published
- 2020
- Full Text
- View/download PDF
8. Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
- Author
-
Lanini, Simone, Scognamiglio, Paola, Mecozzi, Alessandra, Lombardozzi, Lorella, Vullo, Vincenzo, Angelico, Mario, Gasbarrini, Antonio, Taliani, Gloria, Attili, Adolfo Francesco, Perno, Carlo Federico, De Santis, Adriano, Puro, Vincenzo, Cerqua, Fabio, D'Offizi, Gianpiero, Pellicelli, Adriano, Armignacco, Orlando, Mennini, Francesco Saverio, Siciliano, Massimo, Girardi, Enrico, Panella, Vincenzo, Ippolito, Giuseppe, Sarrecchia, C., Di Paolo, M. D., Francioso, S., Brega, A., Lenci, I., Sarmati, L., Pompili, Maurizio, Grieco, Antonio, Tamburrini, Enrica, Apaccini, R., Miele, Luca, D'Ettorre, G., Mezzaroma, I., Furlan, C., Accapezzato, D., Paoletti, F., Merili, M., Corradini, S., Sereno, S., Fimiani, C., Mastropietro, C., Labbadia, G., Gentile, Giuseppe, Pasquazzi, C., Marignani, M., Guarisco, R., Puoti, C., Spilabotti, L., Montalbano, M., Boumis, E., Visco-Comandini, U., Zaccarelli, M., Ammassari, A., Lionetti, R., Murachelli, S., Loiacono, L., Antinori, Armando, Noto, P., Palmieri, F., Cicalini, S., Cerilli, S., Sampaolesi, A., Vincenzi, L., Bellagamba, R., Galati, V., Abdeddaim, A., Iacomi, F., Iannicelli, G., Mastroianni, Chiara, Lichtner, M., Ridola, L., Coluzzi, T., Mercurio, V., Del Borgo, C., Fondacaro, L., Cerasari, G., Guarascio, P., D'Ambrosio, C., Starnini, G., Caterini, A., Villani, Emanuele Rocco, Sarracino, L., Casinelli, K., Moretti, A., Vespasiani, U., Galati, G., Cecere, R., Bonaventura, M., and Scudieri, M.
- Subjects
Male ,Cirrhosis ,Investigational ,chronic hepatitis c ,clinical study ,direct acting antiviral ,hepatitis c virus ,liver cirrhosis ,liver damage ,mixed effect model ,multicenter cohort study ,new therapy ,treatment efficacy ,Logistic regression ,Chronic hepatitis C ,Cohort Studies ,0302 clinical medicine ,Clinical study ,Direct acting antiviral ,Hepatitis C virus ,Liver cirrhosis ,Liver damage ,Mixed effect model ,Multicenter cohort study ,New therapy ,Treatment efficacy ,Adult ,Aged ,Aged, 80 and over ,Antiviral Agents ,Drug Therapy, Combination ,Drugs, Investigational ,Female ,Follow-Up Studies ,Hepatitis C, Chronic ,Humans ,Liver Cirrhosis ,Middle Aged ,Therapies, Investigational ,80 and over ,030212 general & internal medicine ,Stage (cooking) ,Chronic ,Confounding ,Drugs ,Hepatitis C ,Infectious Diseases ,Cohort ,Combination ,Settore SECS-P/03 - Scienza delle Finanze ,030211 gastroenterology & hepatology ,Cohort study ,Research Article ,medicine.medical_specialty ,Side effect ,Hepatitis C virus, Chronic hepatitis C, Liver cirrhosis, Direct acting antiviral, Multicenter cohort study, Mixed effect model, Liver damage, Treatment efficacy, Clinical study, New therapy ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,Drug Therapy ,Internal medicine ,medicine ,lcsh:RC109-216 ,business.industry ,Settore MED/09 - MEDICINA INTERNA ,medicine.disease ,Clinical trial ,Therapies ,business - Abstract
Background Management of chronic hepatitis C (CHC) has significantly accelerated in the last few years. Currently, second generation direct acting antivirals (DAAs) promise clearance of infection in most of patients. Here we present the results of the first analysis carried out on data of Lazio clinical network for DAAs. Methods The study was designed as a multicenter cohort: a) to assess the evolution of treatment during the first 24 months of the activity of the Clinical Network; b) to report overall efficacy of treatments; c) to analyze potential factors associated with lack of virological response at 12 weeks after therapy (SVR12); d) to evaluate the variation of ALT at baseline and 12 weeks after therapy in those who achieved SVR12 in comparison to those who did not. Analyses of efficacy were carried out with multilevel mixed effect logistic regression model. ALT temporal variation was assessed by mixed effect model mixed models with random intercept at patient’s level and random slope at the level of the time; i.e. either before or after therapy. Results Between 30 December 2014 and 31 December 2016 5279 patients started a DAA treatment; of those, 5127 (in 14 clinical centers) had completed the 12-week follow-up. Overall proportion of SVR12 was 93.41% (N = 4780) with no heterogeneity between the 14 clinical centers. Interruption as the consequence of severe side effect was very low (only 23 patients). Unadjusted analysis indicates that proportion of SVR12 significantly changes according to patient’s baseline characteristics, however after adjusting for potential confounders only adherence to current guidelines, stage of liver diseases, gender, transplant and HIV status were independently associated with the response to therapy. Analysis of ALT temporal variation showed that ALT level normalized in most, but not, all patients who achieved SVR12. Conclusion Our study confirmed the extraordinary efficacy of DAAs outside clinical trials. The advantage of DAAs was particularly significant for those patients who were previously considered as difficult-to-treat and did not have treatment options before DAAs era. Intervention based on network of select centers and prioritization of patients according to diseases severity was successful. Further studies are needed to establish whether clearance of HCV after DAAs therapy can arrest or even revert liver fibrosis in non-cirrhotic patients and/or improve life quality and expectancy in those who achieve SVR12 with cirrhosis.
- Published
- 2018
9. Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues*
- Author
-
Santoro, M M, Sabin, C, Forbici, F, Bansi, L, Dunn, D, Fearnhill, E, Boumis, E, Nicastri, E, Antinori, A, Palamara, G, Callegaro, A, Francisci, D, Zoncada, A, Maggiolo, F, Zazzi, M, Perno, C F, Ceccherini-Silberstein, F, and Mussini, C
- Published
- 2013
- Full Text
- View/download PDF
10. Cardiovascular risk profile and events in HIV-infected patients: a prospective cohort study: O563
- Author
-
Cicalini, S., Chinello, P., Piselli, P., Grilli, E., Musso, M., Boumis, E., and Petrosillo, N.
- Published
- 2012
11. Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage
- Author
-
De Nardo, Pasquale, primary, Gentilotti, Elisa, additional, Mazzaferri, Fulvia, additional, Cremonini, Eleonora, additional, Hansen, Paul, additional, Goossens, Herman, additional, Tacconelli, Evelina, additional, Durante Mangoni, E., additional, Florio, L.L., additional, Zampino, R., additional, Mele, F., additional, Gentile, I., additional, Pinchera, B., additional, Coppola, N., additional, Pisaturo, M., additional, Luzzati, R., additional, Petrosillo, N., additional, Nicastri, E., additional, Corpolongo, A., additional, Cataldo, M.A., additional, D’Abramo, A., additional, Maffongelli, G., additional, Scorzolini, L., additional, Palazzolo, C., additional, Boumis, E., additional, Pan, A., additional, D’Arminio Monforte, A., additional, Bai, F., additional, Antinori, S., additional, De Rosa, F.G., additional, Corcione, S., additional, Lupia, T., additional, Pinna, S.M., additional, Scabini, S., additional, Canta, F., additional, Belloro, S., additional, Bisoffi, Z., additional, Angheben, A., additional, Gobbi, F., additional, Turcato, E., additional, Ronzoni, N., additional, Moro, L., additional, Calabria, S., additional, Rodari, P., additional, Bertoli, G., additional, Marasca, G., additional, Puoti, M., additional, Gori, A., additional, Bandera, A., additional, Mangioni, D., additional, Rizzi, M., additional, Castelli, F., additional, Montineri, A., additional, Coco, C.A., additional, Maresca, M., additional, Frasca, M., additional, Aquilini, D., additional, Vincenzi, M., additional, Lambertenghi, L., additional, De Rui, M.E., additional, Razzaboni, E., additional, Cattaneo, P., additional, Visentin, A., additional, Erbogasto, A., additional, Dalla Vecchia, I., additional, Coledan, I., additional, Vecchi, M., additional, Be, G., additional, Motta, L., additional, Zaffagnini, A., additional, Auerbach, N., additional, Del Bravo, P., additional, Azzini, A.M., additional, Righi, E., additional, Carrara, E., additional, Savoldi, A., additional, Sibani, M., additional, Lattuada, E., additional, Carolo, G., additional, Cordioli, M., additional, Soldani, F., additional, Pezzani, M.D., additional, Avallone, S., additional, Bruno, R., additional, Ricciardi, A., additional, Saggese, M.P., additional, and Malerba, G., additional
- Published
- 2020
- Full Text
- View/download PDF
12. Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
- Author
-
Di Giambenedetto, S, Fabbiani, M, Quiros Roldan, E, Latini, A, D'Ettorre, G, Antinori, A, Castagna, A, Orofino, G, Francisci, D, Chinello, P, Madeddu, G, Grima, P, Rusconi, S, Di Pietro, M, Mondi, A, Ciccarelli, N, Borghetti, A, Foca, E, Colafigli, M, De Luca, A, Cauda, R, Baldonero, E, Belmonti, S, D'Avino, A, Gagliardini, R, Lamonica, S, Lombardi, F, Sidella, L, Tamburrini, E, Visconti, E, Giacometti, A, Barchiesi, F, Castelli, P, Cirioni, O, Mazzocato, S, Blanc, P, Degli Esposti, A, Del Pin, B, Mariabelli, E, Marini, S, Poggi, A, Amadasi, S, Apostoli, A, Biasi, L, Bonito, A, Brianese, N, Compostella, S, Ferraresi, A, Motta, D, Mughini, M, Celesia, B, Gussio, M, Sofia, S, Tana, M, Tundo, P, Viscoli, C, De Hoffer, L, Di Biagio, A, Grignolo, S, Parisini, A, Schenone, E, Taramasso, L, Manconi, P, Boccone, A, Ortu, F, Piano, P, Serusi, L, Puoti, M, Moioli, M, Rossotti, R, Travi, G, Ventura, F, Galli, M, Di Nardo Stuppino, S, Di Cristo, V, Giacomelli, A, Vimercati, V, Viale, P, Gori, A, Rizzardini, G, Capetti, A, Carenzi, L, Mazza, F, Meraviglia, P, Rosa, S, Zucchi, P, Mineo, M, Giuliani, M, Pacifici, A, Pimpinelli, F, Solivetti, F, Stivali, F, Angelici, F, Bellagamba, R, Delle Rose, D, Fezza, R, Libertone, R, Mosti, S, Narciso, P, Nicastri, E, Ottou, S, Tomassi, C, Vlassi, C, Zaccarelli, M, Zoppe, F, Vullo, V, Altavilla, F, Ceccarelli, G, Fantauzzi, A, Gebremeskel, S, Lo Menzo, S, Mezzaroma, I, Tierno, F, Petrosillo, N, Boumis, E, Cicalini, S, Grilli, E, Musso, M, Stella, C, Mura, M, Bagella, P, Mannazzu, M, Soddu, V, Caramello, P, Carcieri, C, Carosella, S, Farenga, M, Scotton, P, Rossi, M, Concia, E, Corsini, F, Gricolo, C, Lanzafame, M, Lattuada, E, Leonardi, S, Rigo, F, Lazzarin, A, Bigoloni, A, Carini, E, Nozza, S, Spagnuolo, V, Belfiori, B, Malincarne, L, Schiaroli, E, Sfara, C, Tosti, A, Sacchini, D, Ruggieri, A, Valdatta, C, Di Giambenedetto S., Fabbiani M., Quiros Roldan E., Latini A., D'Ettorre G., Antinori A., Castagna A., Orofino G., Francisci D., Chinello P., Madeddu G., Grima P., Rusconi S., Di Pietro M., Mondi A., Ciccarelli N., Borghetti A., Foca E., Colafigli M., De Luca A., Cauda R., Baldonero E., Belmonti S., D'Avino A., Gagliardini R., Lamonica S., Lombardi F., Sidella L., Tamburrini E., Visconti E., Giacometti A., Barchiesi F., Castelli P., Cirioni O., Mazzocato S., Blanc P., Degli Esposti A., Del Pin B., Mariabelli E., Marini S., Poggi A., Amadasi S., Apostoli A., Biasi L., Bonito A., Brianese N., Compostella S., Ferraresi A., Motta D., Mughini M. T., Celesia B. M., Gussio M., Sofia S., Tana M., Tundo P., Viscoli C., De Hoffer L., Di Biagio A., Grignolo S., Parisini A., Schenone E., Taramasso L., Manconi P. E., Boccone A., Ortu F., Piano P., Serusi L., Puoti M., Moioli M. C., Rossotti R., Travi G., Ventura F., Galli M., Di Nardo Stuppino S., Di Cristo V., Giacomelli A., Vimercati V., Viale P., Gori A., Rizzardini G., Capetti A., Carenzi L., Mazza F., Meraviglia P., Rosa S., Zucchi P., Mineo M., Giuliani M., Pacifici A., Pimpinelli F., Solivetti F., Stivali F., Angelici F., Bellagamba R., Delle Rose D., Fezza R., Libertone R., Mosti S., Narciso P., Nicastri E., Ottou S., Tomassi C., Vlassi C., Zaccarelli M., Zoppe F., Vullo V., Altavilla F., Ceccarelli G., Fantauzzi A., Gebremeskel S., Lo Menzo S., Mezzaroma I., Tierno F., Petrosillo N., Boumis E., Cicalini S., Grilli E., Musso M., Stella C., Mura M. S., Bagella P., Mannazzu M., Soddu V., Caramello P., Carcieri C., Carosella S., Farenga M., Scotton P. G., Rossi M. C., Concia E., Corsini F., Gricolo C., Lanzafame M., Lattuada E., Leonardi S., Rigo F., Lazzarin A., Bigoloni A., Carini E., Nozza S., Spagnuolo V., Belfiori B., Malincarne L., Schiaroli E., Sfara C., Tosti A., Sacchini D., Ruggieri A., Valdatta C., Di Giambenedetto, S, Fabbiani, M, Quiros Roldan, E, Latini, A, D'Ettorre, G, Antinori, A, Castagna, A, Orofino, G, Francisci, D, Chinello, P, Madeddu, G, Grima, P, Rusconi, S, Di Pietro, M, Mondi, A, Ciccarelli, N, Borghetti, A, Foca, E, Colafigli, M, De Luca, A, Cauda, R, Baldonero, E, Belmonti, S, D'Avino, A, Gagliardini, R, Lamonica, S, Lombardi, F, Sidella, L, Tamburrini, E, Visconti, E, Giacometti, A, Barchiesi, F, Castelli, P, Cirioni, O, Mazzocato, S, Blanc, P, Degli Esposti, A, Del Pin, B, Mariabelli, E, Marini, S, Poggi, A, Amadasi, S, Apostoli, A, Biasi, L, Bonito, A, Brianese, N, Compostella, S, Ferraresi, A, Motta, D, Mughini, M, Celesia, B, Gussio, M, Sofia, S, Tana, M, Tundo, P, Viscoli, C, De Hoffer, L, Di Biagio, A, Grignolo, S, Parisini, A, Schenone, E, Taramasso, L, Manconi, P, Boccone, A, Ortu, F, Piano, P, Serusi, L, Puoti, M, Moioli, M, Rossotti, R, Travi, G, Ventura, F, Galli, M, Di Nardo Stuppino, S, Di Cristo, V, Giacomelli, A, Vimercati, V, Viale, P, Gori, A, Rizzardini, G, Capetti, A, Carenzi, L, Mazza, F, Meraviglia, P, Rosa, S, Zucchi, P, Mineo, M, Giuliani, M, Pacifici, A, Pimpinelli, F, Solivetti, F, Stivali, F, Angelici, F, Bellagamba, R, Delle Rose, D, Fezza, R, Libertone, R, Mosti, S, Narciso, P, Nicastri, E, Ottou, S, Tomassi, C, Vlassi, C, Zaccarelli, M, Zoppe, F, Vullo, V, Altavilla, F, Ceccarelli, G, Fantauzzi, A, Gebremeskel, S, Lo Menzo, S, Mezzaroma, I, Tierno, F, Petrosillo, N, Boumis, E, Cicalini, S, Grilli, E, Musso, M, Stella, C, Mura, M, Bagella, P, Mannazzu, M, Soddu, V, Caramello, P, Carcieri, C, Carosella, S, Farenga, M, Scotton, P, Rossi, M, Concia, E, Corsini, F, Gricolo, C, Lanzafame, M, Lattuada, E, Leonardi, S, Rigo, F, Lazzarin, A, Bigoloni, A, Carini, E, Nozza, S, Spagnuolo, V, Belfiori, B, Malincarne, L, Schiaroli, E, Sfara, C, Tosti, A, Sacchini, D, Ruggieri, A, Valdatta, C, Di Giambenedetto S., Fabbiani M., Quiros Roldan E., Latini A., D'Ettorre G., Antinori A., Castagna A., Orofino G., Francisci D., Chinello P., Madeddu G., Grima P., Rusconi S., Di Pietro M., Mondi A., Ciccarelli N., Borghetti A., Foca E., Colafigli M., De Luca A., Cauda R., Baldonero E., Belmonti S., D'Avino A., Gagliardini R., Lamonica S., Lombardi F., Sidella L., Tamburrini E., Visconti E., Giacometti A., Barchiesi F., Castelli P., Cirioni O., Mazzocato S., Blanc P., Degli Esposti A., Del Pin B., Mariabelli E., Marini S., Poggi A., Amadasi S., Apostoli A., Biasi L., Bonito A., Brianese N., Compostella S., Ferraresi A., Motta D., Mughini M. T., Celesia B. M., Gussio M., Sofia S., Tana M., Tundo P., Viscoli C., De Hoffer L., Di Biagio A., Grignolo S., Parisini A., Schenone E., Taramasso L., Manconi P. E., Boccone A., Ortu F., Piano P., Serusi L., Puoti M., Moioli M. C., Rossotti R., Travi G., Ventura F., Galli M., Di Nardo Stuppino S., Di Cristo V., Giacomelli A., Vimercati V., Viale P., Gori A., Rizzardini G., Capetti A., Carenzi L., Mazza F., Meraviglia P., Rosa S., Zucchi P., Mineo M., Giuliani M., Pacifici A., Pimpinelli F., Solivetti F., Stivali F., Angelici F., Bellagamba R., Delle Rose D., Fezza R., Libertone R., Mosti S., Narciso P., Nicastri E., Ottou S., Tomassi C., Vlassi C., Zaccarelli M., Zoppe F., Vullo V., Altavilla F., Ceccarelli G., Fantauzzi A., Gebremeskel S., Lo Menzo S., Mezzaroma I., Tierno F., Petrosillo N., Boumis E., Cicalini S., Grilli E., Musso M., Stella C., Mura M. S., Bagella P., Mannazzu M., Soddu V., Caramello P., Carcieri C., Carosella S., Farenga M., Scotton P. G., Rossi M. C., Concia E., Corsini F., Gricolo C., Lanzafame M., Lattuada E., Leonardi S., Rigo F., Lazzarin A., Bigoloni A., Carini E., Nozza S., Spagnuolo V., Belfiori B., Malincarne L., Schiaroli E., Sfara C., Tosti A., Sacchini D., Ruggieri A., and Valdatta C.
- Abstract
Background: Combination ART (cART)-related toxicities and costs have prompted the need for treatment simplification. The ATLAS-M trial explored 48 week non-inferior efficacy of simplification to atazanavir/ritonavir + lamivudine versus maintaining three-drug atazanavir/ritonavir-based cART in virologically suppressed patients. Methods: We performed an open-label, multicentre, randomized, non-inferiority study, enrolling HIV-infected adults on atazanavir/ritonavir+two NRTIs, with stable HIV-RNA <50 copies/mL and CD4+>200 cells/mm3. Main exclusion criteria were hepatitis B virus coinfection, past virological failure on or resistance to study drugs, recent AIDS and pregnancy. Patients were randomly assigned 1:1 to either switch to 300mg of atazanavir/ 100mg of ritonavir once daily and 300mg of lamivudine once daily (atazanavir/ritonavir+lamivudine arm) or to continue the previous regimen (atazanavir/ritonavir+two NRTIs arm). The primary study outcome was the maintenance of HIV-RNA <50 copies/mL at week 48 of the ITT-exposed (ITT-e) analysis with switch"failure. The non-inferiority margin was 12%. This study is registered at ClinicalTrials.gov, number NCT01599364. Results: Between July 2011 and June 2014, 266 patients were randomized (133 to each arm). After 48 weeks, the primary study outcome was met by 119 of 133 patients (89.5%) in the atazanavir/ritonavir+lamivudine arm and 106 of 133 patients (79.7%) in the atazanavir/ritonavir+two NRTIs arm [difference atazanavir/ritonavir+ lamivudine versus atazanavir/ritonavir+two NRTIs arm: +9.8% (95% CI+1.2 to+18.4)], demonstrating non-inferiority and superior efficacy of the atazanavir/ritonavir+lamivudine arm. Virological failure occurred in two (1.5%) patients in the atazanavir/ritonavir+lamivudine arm and six (4.5%) patients in the atazanavir/ritonavir+ two NRTIs arm, without resistance selection. A similar proportion of adverse events occurred in both arms. Conclusions: Treatment simplification to atazanavir/rito
- Published
- 2017
13. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient
- Author
-
Boumis, E, Chinello, P, Rocca, C Della, Paglia, M G, Proietti, M F, and Petrosillo, N
- Published
- 2006
14. Post-kala-azar dermal leishmaniasis during highly active anti-retroviral therapy in an HIV-infected patient. Case report: R2192
- Author
-
Boumis, E., Chinello, P., Rocca, C. Della, Paglia, M. G., Proietti, M. F., and Petrosillo, N.
- Published
- 2005
15. Remission of Behçet's disease and keratoconjunctivitis sicca in an HIV-infected patient treated with HAART
- Author
-
Cicalini, S, Gigli, B, Palmieri, F, Boumis, E, Froio, N, and Petrosillo, N
- Published
- 2004
16. Cardiovascular neurovegetative dysfunction in HIV-infected patients
- Author
-
Cicalini, S., Raimondi, G., Noto, P., Boumis, E., Sacco, S., Saltini, C., and Petrosillo, N.
- Published
- 2004
17. Clinical characteristics of infective endocarditis: descriptive review of 262 episodes and risk factors for death
- Author
-
Cicalini, S., Angeletti, C., Boumis, E., Palmieri, F., and Petrosillo, N.
- Published
- 2004
18. Changing Patterns in the Etiology of HIV-Associated Bacterial Pneumonia in the Era of Highly Active Antiretroviral Therapy
- Author
-
Boumis, E., Petrosillo, N., Girardi, E., De Carli, G., Armignacco, O., Visca, P., and Ippolito, G.
- Published
- 2001
- Full Text
- View/download PDF
19. Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis
- Author
-
Tocci, G., Antonelli, L., Boumis, E., Colaiacomo, M., Guarascio, P., Struglia, C., Tossini, G., Visco, G., De Bac, C., editor, Taliani, G., editor, and Gerlich, W. H., editor
- Published
- 1992
- Full Text
- View/download PDF
20. Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
- Author
-
Di Giambenedetto, S., Fabbiani, M., Quiros Roldan, E., Latini, A., D'Ettorre, G., Antinori, A., Castagna, A., Orofino, G., Francisci, D., Chinello, P., Madeddu, G., Grima, P., Rusconi, S., Di Pietro, M., Mondi, A., Ciccarelli, N., Borghetti, A., Focà, E., Colafigli, M., De Luca, A., Cauda, R., Baldonero, E., Belmonti, S., D'Avino, A., Gagliardini, R., Lamonica, S., Lombardi, F., Sidella, L., Tamburrini, E., Visconti, E., Giacometti, A., Barchiesi, F., Castelli, P., Cirioni, O., Mazzocato, S., Blanc, P., Degli Esposti, A., Del Pin, B., Mariabelli, E., Marini, S., Poggi, A., Amadasi, S., Apostoli, A., Biasi, L., Bonito, A., Brianese, N., Compostella, S., Ferraresi, A., Motta, D., Mughini, M. T., Celesia, B. M., Gussio, M., Sofia, S., Tana, M., Tundo, P., Viscoli, C., De Hoffer, L., Di Biagio, A., Grignolo, S., Parisini, A., Schenone, E., Taramasso, L., Manconi, P. E., Boccone, A., Ortu, F., Piano, P., Serusi, L., Puoti, M., Moioli, M. C., Rossotti, R., Travi, G., Ventura, F., Galli, M., Di Nardo Stuppino, S., Di Cristo, V., Giacomelli, A., Vimercati, V., Viale, P., Gori, A., Rizzardini, G., Capetti, A., Carenzi, L., Mazza, F., Meraviglia, P., Rosa, S., Zucchi, P., Mineo, M., Giuliani, M., Pacifici, A., Pimpinelli, F., Solivetti, F., Stivali, F., Angelici, F., Bellagamba, R., Delle Rose, D., Fezza, R., Libertone, R., Mosti, S., Narciso, P., Nicastri, E., Ottou, S., Tomassi, C., Vlassi, C., Zaccarelli, M., Zoppè, F., Vullo, V., Altavilla, F., Ceccarelli, G., Fantauzzi, A., Gebremeskel, S., Lo Menzo, S., Mezzaroma, I., Tierno, F., Petrosillo, N., Boumis, E., Cicalini, S., Grilli, E., Musso, M., Stella, C., Mura, M. S., Bagella, P., Mannazzu, M., Soddu, V., Caramello, P., Carcieri, C., Carosella, S., Farenga, M., Scotton, P. G., Rossi, M. C., Concia, E., Corsini, F., Gricolo, C., Lanzafame, M., Lattuada, E., Leonardi, S., Rigo, F., Lazzarin, A., Bigoloni, A., Carini, E., Nozza, S., Spagnuolo, V., Belfiori, B., Malincarne, L., Schiaroli, E., Sfara, C., Tosti, A., Sacchini, D., Ruggieri, A., Valdatta, C., Di Giambenedetto, S, Fabbiani, M, Quiros Roldan, E, Latini, A, D'Ettorre, G, Antinori, A, Castagna, A, Orofino, G, Francisci, D, Chinello, P, Madeddu, G, Grima, P, Rusconi, S, Di Pietro, M, Mondi, A, Ciccarelli, N, Borghetti, A, Foca, E, Colafigli, M, De Luca, A, Cauda, R, Baldonero, E, Belmonti, S, D'Avino, A, Gagliardini, R, Lamonica, S, Lombardi, F, Sidella, L, Tamburrini, E, Visconti, E, Giacometti, A, Barchiesi, F, Castelli, P, Cirioni, O, Mazzocato, S, Blanc, P, Degli Esposti, A, Del Pin, B, Mariabelli, E, Marini, S, Poggi, A, Amadasi, S, Apostoli, A, Biasi, L, Bonito, A, Brianese, N, Compostella, S, Ferraresi, A, Motta, D, Mughini, M, Celesia, B, Gussio, M, Sofia, S, Tana, M, Tundo, P, Viscoli, C, De Hoffer, L, Di Biagio, A, Grignolo, S, Parisini, A, Schenone, E, Taramasso, L, Manconi, P, Boccone, A, Ortu, F, Piano, P, Serusi, L, Puoti, M, Moioli, M, Rossotti, R, Travi, G, Ventura, F, Galli, M, Di Nardo Stuppino, S, Di Cristo, V, Giacomelli, A, Vimercati, V, Viale, P, Gori, A, Rizzardini, G, Capetti, A, Carenzi, L, Mazza, F, Meraviglia, P, Rosa, S, Zucchi, P, Mineo, M, Giuliani, M, Pacifici, A, Pimpinelli, F, Solivetti, F, Stivali, F, Angelici, F, Bellagamba, R, Delle Rose, D, Fezza, R, Libertone, R, Mosti, S, Narciso, P, Nicastri, E, Ottou, S, Tomassi, C, Vlassi, C, Zaccarelli, M, Zoppe, F, Vullo, V, Altavilla, F, Ceccarelli, G, Fantauzzi, A, Gebremeskel, S, Lo Menzo, S, Mezzaroma, I, Tierno, F, Petrosillo, N, Boumis, E, Cicalini, S, Grilli, E, Musso, M, Stella, C, Mura, M, Bagella, P, Mannazzu, M, Soddu, V, Caramello, P, Carcieri, C, Carosella, S, Farenga, M, Scotton, P, Rossi, M, Concia, E, Corsini, F, Gricolo, C, Lanzafame, M, Lattuada, E, Leonardi, S, Rigo, F, Lazzarin, A, Bigoloni, A, Carini, E, Nozza, S, Spagnuolo, V, Belfiori, B, Malincarne, L, Schiaroli, E, Sfara, C, Tosti, A, Sacchini, D, Ruggieri, A, Valdatta, C, Roldan, Eq, Focà, E, and on behalf of the Atlas-M Study, Group
- Subjects
Male ,0301 basic medicine ,HIV Infections ,ART HIV ,Gastroenterology ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,immune system diseases ,law ,Antiretroviral Therapy, Highly Active ,HIV Infection ,Pharmacology (medical) ,Viral ,030212 general & internal medicine ,Adult ,Atazanavir Sulfate ,Coinfection ,Drug Therapy, Combination ,Female ,HIV-1 ,Humans ,Lamivudine ,Middle Aged ,RNA, Viral ,Ritonavir ,Viral Load ,Young Adult ,Pharmacology ,Infectious Diseases ,virus diseases ,dual therapy ,Combination ,Viral load ,Human ,medicine.drug ,Microbiology (medical) ,medicine.medical_specialty ,030106 microbiology ,Antiretroviral Therapy ,Settore MED/17 - MALATTIE INFETTIVE ,03 medical and health sciences ,Drug Therapy ,Internal medicine ,medicine ,Highly Active ,Adverse effect ,business.industry ,Surgery ,Atazanavir ,Regimen ,RNA ,business - Abstract
Background: Combination ART (cART)-related toxicities and costs have prompted the need for treatment simplification. The ATLAS-M trial explored 48 week non-inferior efficacy of simplification to atazanavir/ritonavir + lamivudine versus maintaining three-drug atazanavir/ritonavir-based cART in virologically suppressed patients. Methods: We performed an open-label, multicentre, randomized, non-inferiority study, enrolling HIV-infected adults on atazanavir/ritonavir+two NRTIs, with stable HIV-RNA 200 cells/mm3. Main exclusion criteria were hepatitis B virus coinfection, past virological failure on or resistance to study drugs, recent AIDS and pregnancy. Patients were randomly assigned 1:1 to either switch to 300mg of atazanavir/ 100mg of ritonavir once daily and 300mg of lamivudine once daily (atazanavir/ritonavir+lamivudine arm) or to continue the previous regimen (atazanavir/ritonavir+two NRTIs arm). The primary study outcome was the maintenance of HIV-RNA
- Published
- 2017
21. ALPHA INTERFERON 2b PLUS RIBAVIRIN IN INTERFERON NON-RESPONDERS OR RELAPSING CHRONIC HEPATITIS C PATIENTS
- Author
-
Longo, M. A., Boumis, E., Palmieri, F., Noto, P., Struglia, C., Capecchi, A., Zechini, F., Franci, P., Demartino, G., and Pellicelli, A. M.
- Published
- 1999
22. Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis
- Author
-
Tocci, G., primary, Antonelli, L., additional, Boumis, E., additional, Colaiacomo, M., additional, Guarascio, P., additional, Struglia, C., additional, Tossini, G., additional, and Visco, G., additional
- Published
- 1992
- Full Text
- View/download PDF
23. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
- Author
-
Bartoletti, M., primary, Giannella, M., additional, Lewis, R., additional, Caraceni, P., additional, Tedeschi, S., additional, Paul, M., additional, Schramm, C., additional, Bruns, T., additional, Merli, M., additional, Cobos-Trigueros, N., additional, Seminari, E., additional, Retamar, P., additional, Muñoz, P., additional, Tumbarello, M., additional, Burra, P., additional, Torrani Cerenzia, M., additional, Barsic, B., additional, Calbo, E., additional, Maraolo, A.E., additional, Petrosillo, N., additional, Galan-Ladero, M.A., additional, D'Offizi, G., additional, Bar Sinai, N., additional, Rodríguez-Baño, J., additional, Verucchi, G., additional, Bernardi, M., additional, Viale, P., additional, Campoli, C., additional, Siccardi, G., additional, Ambretti, S., additional, Stallmach, A., additional, Venditti, M., additional, Lucidi, C., additional, Ludovisi, S., additional, De Cueto, M., additional, Navarro, M.D., additional, Lopez Cortes, E., additional, Bouza, E., additional, Valerio, M., additional, Eworo, A., additional, Losito, R., additional, Senzolo, M., additional, Nadal, E., additional, Ottobrelli, A., additional, Varguvic, M., additional, Badia, C., additional, Borgia, G., additional, Gentile, I., additional, Buonomo, A.R., additional, Boumis, E., additional, Beteta-Lopez, A., additional, Rianda, A., additional, Taliani, G., additional, and Grieco, S., additional
- Published
- 2018
- Full Text
- View/download PDF
24. Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals
- Author
-
Trotta MP, Ammassari A, Murri R, Marconi P, Zaccarelli M, Cozzi Lepri A, Acinapura R, Abrescia N, De Longis P, Tozzi V, Scalzini A, Vullo V, Boumis E, Nasta P, Monforte A, Antinori A, AdICoNA, AdeSpall Study Group, PIAZZA, MARCELLO, NAPPA, SALVATORE, Trotta, Mp, Ammassari, A, Murri, R, Marconi, P, Zaccarelli, M, Cozzi Lepri, A, Acinapura, R, Abrescia, N, De Longis, P, Tozzi, V, Scalzini, A, Vullo, V, Boumis, E, Nasta, P, Monforte, A, Antinori, A, Adicona, AdeSpall Study, Group, Piazza, Marcello, and Nappa, Salvatore
- Subjects
Adult ,Male ,Self-Assessment ,medicine.medical_specialty ,antiretroviral ,Sexual dysfunction ,HIV Infections ,Cohort Studies ,Fat accumulation ,Antiretroviral Therapy, Highly Active ,Surveys and Questionnaires ,Internal medicine ,Hiv infected ,Humans ,Medicine ,Sexual Dysfunctions, Psychological ,adherence ,Patient compliance ,business.industry ,Public Health, Environmental and Occupational Health ,HIV ,Middle Aged ,Antiretroviral therapy ,Infectious Diseases ,Increased risk ,Physical therapy ,Patient Compliance ,Female ,medicine.symptom ,business ,Symptom score ,Cohort study - Abstract
Increased occurrence of sexual dysfunction (SD) among patients treated with highly active antiretroviral therapy (HAART) has been reported. To assess prevalence of self-reported SD and to identify factors related to this alteration with special focus to its relationship with adherence behavior, we conducted an intercohort analysis among HIV-infected persons treated with HAART. In an anonymous questionnaire investigating HAART nonadherence, patients were asked to report the occurrence of dysfunction in sexual activity over the previous 4 weeks. Among 612 participants, 125 (21%) reported some degree of SD. "Moderate"/"severe" alterations were reported in 6% and were independently associated with self-reported worsening of viro-immunological parameters (OR 3.90; 95% CI 1.08-14.18), higher symptom score (OR 1.13; 95% CI 1.05-1.22), and reporting abnormal fat accumulation (OR 4.33; 95% CI 1.55-12.11). Furthermore, nonadherent persons had an increased risk of SD (OR 3.44; 95% CI 1.30-9.08). In conclusion, patients' perceived SD represents a relevant problem for HIV-infected persons treated with antiretrovirals and is strongly associated with suboptimal HAART adherence.
- Published
- 2008
25. Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort
- Author
-
Pinnetti, C, Di Giambenedetto, Simona, Maggiolo, F, Fabbiani, Massimiliano, Sterrantino, G, Latini, A, Lorenzini, P, Ammassari, A, Loiacono, L, Bellagamba, R, Boumis, E, Cauda, Roberto, Antinori, A, Zaccarelli, M., Di Giambenedetto, Simona (ORCID:0000-0001-6990-5076), Cauda, Roberto (ORCID:0000-0002-1498-4229), Pinnetti, C, Di Giambenedetto, Simona, Maggiolo, F, Fabbiani, Massimiliano, Sterrantino, G, Latini, A, Lorenzini, P, Ammassari, A, Loiacono, L, Bellagamba, R, Boumis, E, Cauda, Roberto, Antinori, A, Zaccarelli, M., Di Giambenedetto, Simona (ORCID:0000-0001-6990-5076), and Cauda, Roberto (ORCID:0000-0002-1498-4229)
- Abstract
No abstract available.
- Published
- 2015
26. Yersinia pseudotuberculosis septicemia in an HIV-infected patient failed HAART
- Author
-
ANTINORI A, PAGLIA MG, MARCONI P, FESTA A, ALBA L, BOUMIS E, PUCILLO LP, VISCA, PAOLO, Antinori, A, Paglia, Mg, Marconi, P, Festa, A, Alba, L, Boumis, E, Pucillo, Lp, and Visca, Paolo
- Published
- 2004
27. The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis
- Author
-
Scognamiglio, Paola, Chiaradia, Giacomina, De Carli, Gabriella, Giuliani, Massimo, Mastroianni, Claudio Maria, Aviani Barbacci, Stefano, Buonomini, Anna R., Grisetti, Susanna, Sampaolesi, Alessandro, Corpolongo, Angela, Orchi, Nicoletta, Puro, Vincenzo, Ippolito, Giuseppe, Girardi, Enrico, Girardi, E., Orchi, N., Angeletti, C., Balzano, R., Elia, P., Navarra, A., Nurra, G., Palummieri, A., Alba, L., Ammassari, A., Antinori, A., Baldini, F., Bellagamba, R., Bevilacqua, N., Boumis, E., Capobianchi, M. R., Cerilli, S., Chinello, P., Corpolongo, A., D'Arrigo, R., De Carli, G., Null, D'Offizig, Forbici, F., Fusco, F. M., Galati, V., Ghirga, P., Giancola, L., Gori, C., Grisetti, S., Lauria, F. N., Liuzzi, G., Marconi, P., Mariano, A., Narciso, P., Nicastri, E., Noto, P., Palmieri, A. F., Perno, C. F., Petrosillo, N., Pisapia, R., Pittalis, S., Puro, V., Sampaolesi, A., Scognamiglio, P., Sciarrone, M. R., Selleri, M., Sias, C., Topino, S., Tozzi, V., Vincenzi, L., Visco Comandini, U., Vlassi, C., Zaccarelli, M., Zaniratti, S., Vullo, Vincenzo, Falciano, Mario, Andreoni, M., Sarmati, L., Buonomini, A. R., Di Carlo, A., Giuliani, M., Brancatella, R., Maggi, T., Errico, F., De Filippis, A., Di Bacco, R., Schito, S., Gattari, P., Spizzichino, L., Francesconi, M., Pace, G., Gallo, I., Anzalone, E., Tacconi, L., Mercurio, V. S., Lichtner, Miriam, Natalini Raponi, G., Pitorri, A., Caterini, A., and Aviani Barbacci, S.
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Delayed Diagnosis ,Tuberculosis ,Adolescent ,HIV Infections ,Disease ,HIV testing ,Indicator diseases ,Late diagnosis ,Sexually transmitted infections ,Aged ,Aged, 80 and over ,CD4 Lymphocyte Count ,Diagnostic Tests, Routine ,Female ,Humans ,Italy ,Middle Aged ,Retrospective Studies ,Risk Factors ,Young Adult ,Infectious Diseases ,Medical microbiology ,Diagnostic Tests ,80 and over ,Medicine ,Routine ,Young adult ,business.industry ,virus diseases ,Seborrhoeic dermatitis ,Retrospective cohort study ,medicine.disease ,Settore MED/17 ,Surgery ,Population study ,business ,Viral hepatitis ,Research Article - Abstract
Background The aim of our work was to evaluate the potential impact of the European policy of testing for HIV all individuals presenting with an indicator disease, to prevent late diagnosis of HIV. We report on a retrospective analysis among individuals diagnosed with HIV to assess whether a history of certain diseases prior to HIV diagnosis was associated with the chance of presenting late for care, and to estimate the proportion of individuals presenting late who could have been diagnosed earlier if tested when the indicator disease was diagnosed. Methods We studied a large cohort of individuals newly diagnosed with HIV infection in 13 counselling and testing sites in the Lazio Region, Italy (01/01/2004-30/04/2009). Considered indicator diseases were: viral hepatitis infection (HBV/HCV), sexually transmitted infections, seborrhoeic dermatitis and tuberculosis. Logistic regression analysis was performed to estimate association of occurrence of at least one indicator disease with late HIV diagnosis. Results In our analysis, the prevalence of late HIV diagnosis was 51.3% (890/1735). Individuals reporting at least one indicator disease before HIV diagnosis (29% of the study population) had a lower risk of late diagnosis (OR = 0.7; 95%CI: 0.5-0.8) compared to those who did not report a previous indicator disease. 52/890 (5.8%) late presenters were probably already infected at the time the indicator disease was diagnosed, a median of 22.6 months before HIV diagnosis. Conclusions Our data suggest that testing for HIV following diagnosis of an indicator disease significantly decreases the probability of late HIV diagnosis. Moreover, for 5.5% of late HIV presenters, diagnosis could have been anticipated if they had been tested when an HIV indicator disease was diagnosed. However, this strategy for enhancing early HIV diagnosis needs to be complemented by client-centred interventions that aim to increase awareness in people who do not perceive themselves as being at risk for HIV.
- Published
- 2013
28. Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues
- Author
-
Santoro, M, Sabin, C, Forbici, F, Bansi, L, Dunn, D, Fearnhill, E, Boumis, E, Nicastri, E, Antinori, A, Palamara, G, Callegaro, A, Francisci, Daniela, Zoncada, A, Maggiolo, F, Zazzi, M, Perno, C, Ceccherini Silberstein, F, and Mussini, C.
- Subjects
Adult ,Male ,genotypic resistance test ,Anti-HIV Agents ,Drug Resistance ,Organophosphonates ,Antiretroviral Therapy ,HIV Infections ,Deoxycytidine ,Antiretroviral Therapy, Highly Active ,Drug Resistance, Viral ,Emtricitabine ,Humans ,Highly Active ,Viral ,Treatment Failure ,Tenofovir ,virological failure ,resistance to reverse transcriptase inhibitors ,Adenine ,Middle Aged ,Viral Load ,Settore MED/07 - Microbiologia e Microbiologia Clinica ,Dideoxynucleosides ,HIV Reverse Transcriptase ,CD4 Lymphocyte Count ,Drug Combinations ,first-line regimen ,Female ,HIV-1 ,Lamivudine ,Thymidine ,Zidovudine - Abstract
We evaluated the emergence of drug resistance in patients failing first-line regimens containing one nonnucleoside reverse transcriptase inhibitor (NNRTI) administered with zidovudine (ZDV) + lamivudine (the ZDV group) or non-thymidine analogues (non-TAs) (tenofovir or abacavir, + lamivudine or emtricitabine; the non-TA group).Three hundred HIV-1-infected patients failing a first-line NNRTI-containing regimen (nevirapine, n = 148; efavirenz, n = 152) were included in the analysis. Virological failure was defined as viraemia ≥ 400 HIV-1 RNA copies/mL for the first time at least 6 months after starting the NNRTI-based regimen. For each patient, a genotypic resistance test at failure was available. The presence of drug-resistance mutations in HIV-1 reverse transcriptase was evaluated by comparing patients treated with NNRTI + zidovudine + lamivudine vs. those treated with NNRTI + non-TA.A total of 208 patients were failing with NNRTI + zidovudine + lamivudine and 92 with NNRTI + non-TA. No significant differences were observed between the non-TA group and the ZDV group regarding the time of virological failure [median (interquartile range): 12 (8-25) vs. 13 (9-32) months, respectively; P = 0.119] and viraemia [median (interquartile range): 4.0 (3.2-4.9) vs. 4.0 (3.3-4.7) log₁₀ copies/mL, respectively; P = 0.894]. Resistance to reverse transcriptase inhibitors (RTIs) occurred at a significant lower frequency in the non-TA group than in the ZDV group (54.3 vs. 75.5%, respectively; P = 0.001). This difference was mainly attributable to a significantly lower prevalence of NNRTI resistance (54.3 vs. 74.0%, respectively; P = 0.002) and of the nucleoside reverse transcriptase inhibitor (NRTI) mutation M184V (23.9 vs. 63.5%, respectively; P 0.001) in the non-TA group compared with the ZDV group. As expected, the mutation K65R was found only in the non-TA group (18.5%; P 0.001).At first-line regimen failure, a lower prevalence of RTI resistance was found in patients treated with NNRTI + non-TA compared with those treated with NNRTI + zidovudine + lamivudine. These results confirm that the choice of backbone may influence the prevalence of drug resistance at virological failure.
- Published
- 2013
29. Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
- Author
-
Pinnetti, C, Di Giambenedetto, Simona, Maggiolo, F, Lorenzini, P, Fabbiani, M, Tommasi, C, Latini, A, Ammassari, A, Loiacono, L, Sterrantino, G, Bellagamba, R, Boumis, E, Antinori, A, Zaccarelli, M., Di Giambenedetto, Simona (ORCID:0000-0001-6990-5076), Pinnetti, C, Di Giambenedetto, Simona, Maggiolo, F, Lorenzini, P, Fabbiani, M, Tommasi, C, Latini, A, Ammassari, A, Loiacono, L, Sterrantino, G, Bellagamba, R, Boumis, E, Antinori, A, Zaccarelli, M., and Di Giambenedetto, Simona (ORCID:0000-0001-6990-5076)
- Abstract
To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.
- Published
- 2014
30. EVALUATION OF DRUG RESISTANCE EMERGENCE IN HIV-1 INFECTED PATIENTS FAILING A FIRST-LINE HIGHLY ACTIVE ANTIRETROVIRAL THERAPY CONTAINING NNRTIS WITH OR WITHOUT THYMIDINE ANALOGUES
- Author
-
Santoro, M. M., Silberstein, F. Ceccherini, Forbici, F., Zaccarelli, M., Boumis, E., Palamara, G., Callegaro, A., Francisci, D., Carnevale, G., Maggiolo, F., Narciso, P., Antinori, A., Maurizio Zazzi, and Mussini, C.
- Published
- 2009
31. [Guidelines for the management of HCV infection in HIV-infected patients. Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani]
- Author
-
Antonucci G, Antinori A, Boumis E, De Longis P, Gentile M, Girardi E, Fn, Lauria, Narciso P, Noto P, Palmieri F, Oliva A, Petrosillo N, Rosati S, Urso R, Tocci G, Tozzi V, Visco Comandini U, and Giuseppe Ippolito
- Subjects
Liver Cirrhosis ,Clinical Trials as Topic ,Evidence-Based Medicine ,Anti-HIV Agents ,Disease Management ,HIV Infections ,Pilot Projects ,Comorbidity ,Antiviral Agents ,Hepatitis C ,Treatment Outcome ,Antiretroviral Therapy, Highly Active ,Humans ,RNA, Viral ,Drug Interactions ,Viremia ,Chemical and Drug Induced Liver Injury - Abstract
It is crucial to ensure an optimal clinical management of HCV infection in HIV-co-infected persons. The reasons for the development of guidelines on HCV-infection treatment in HIV-infected persons arise from the need for a standardised management of HIV/HCV coinfection in our Institute. The aim of these guidelines are: to clarify principles of clinical management of HCV infection in HIV-infected patients to care-providers; to improve the awareness of HIV-infected patients cared for our Institute on current management of HCV infection; to improve the quality of care on this topic. These guidelines, based on Evidence based Medicine principles, have been developed by a panel of experts, who conducted a systematic review of the literature, mainly taking into account current international recommendations. In the present document, the most frequent clinical presentation occurring in the management of HIV/HCV co-infected patients at our Institution are discussed. The adherence to present guidelines and their effectiveness at our Institution, outcome indicators will be evaluated. The present guidelines cannot entirely substitute the judgement of an expert clinician. However, adherence to these guidelines will contribute to the improvement of the standard of care of HIV/HCV-co-infected persons.
- Published
- 2004
32. Bone Marrow Toxicity in HCV Genotype 5a-Infected Patient after peg-IFN alpha-2a and Ribavirin Therapy
- Author
-
Drapeau, C.M.J., primary, Remotti, D., additional, Noto, P., additional, Capone, A., additional, Boumis, E., additional, and Petrosillo, N., additional
- Published
- 2008
- Full Text
- View/download PDF
33. WORKFLOW DIAGNOSTICO PER LA IDENTIFICAZIONE DI CRYPTOSPORIDIUM SPP. IN CAMPIONI FECALI
- Author
-
Putignani, L., primary, Bordi, E., additional, Cacciò, S., additional, Paglia, M.G., additional, Boumis, E., additional, Petrosillo, N., additional, and Visca, P., additional
- Published
- 2006
- Full Text
- View/download PDF
34. LIVER TRANSPLANTATION IN HIV-HCV CO-INFECTED PATIENTS: SIX CASE REPORTS.
- Author
-
Vennarecci, G, primary, Ettorre, G M., additional, Antonini, M, additional, D’Offizi, G P., additional, Narciso, P, additional, Noto, F, additional, Boumis, E, additional, De Longis, P, additional, Giovannelli, L, additional, Corazza, V, additional, Del Nonno, F, additional, Per racchio, L, additional, Palmieri, G P., additional, Visco, G, additional, and Santoro, E, additional
- Published
- 2004
- Full Text
- View/download PDF
35. 174 Liver transplantation in HIV-HCV co-infected patients: Five case reports
- Author
-
Vennarecci, G., primary, Ettorre, G.M., additional, Antonini, M., additional, Maritti, M., additional, Giovanelli, L., additional, D'Offizi, G., additional, Narciso, P., additional, Noto, P., additional, Boumis, E., additional, De Longis, P., additional, Nasta, P., additional, Carosi, G.P., additional, Del Nonno, F., additional, Perracchio, L., additional, Palmieri, G.P., additional, Santoro, R., additional, Visco, G., additional, and Santoro, E., additional
- Published
- 2004
- Full Text
- View/download PDF
36. Diagnosis of Intra Vascular Catheter-Related Infection
- Author
-
Cicalini, S., primary, Palmieri, F., additional, Noto, P., additional, Boumis, E., additional, and Petrosillo, N., additional
- Published
- 2002
- Full Text
- View/download PDF
37. Occupational hepatitis C virus infection in Italian health care workers. Italian Study Group on Occupational Risk of Bloodborne Infections.
- Author
-
Puro, V, primary, Petrosillo, N, additional, Ippolito, G, additional, Aloisi, M S, additional, Boumis, E, additional, and Ravà, L, additional
- Published
- 1995
- Full Text
- View/download PDF
38. Switching to coformulated rilpivirine/ emtricitabine/ tenofovir in virologically suppressed patients: Data from a multicenter cohort
- Author
-
Pinnetti, C., Di Giambenedetto, S., Maggiolo, F., Fabbiani, M., Sterrantino, G., Latini, A., Lorenzini, P., Adriana Ammassari, Loiacono, L., Bellagamba, R., Boumis, E., Cauda, R., Antinori, A., and Zaccarelli, M.
39. Rhino-orbital zygomycosis secondary to diabetic ketoacidosis in an HIV-positive patient: Case report and literature review [3]
- Author
-
Boumis, E., PIERANGELO CHINELLO, Conte, A., Noto, P., Cicalini, S., Grillo, L. R., and Petrosillo, N.
40. Guidelines for the management of HCV infection in HIV-infected patients | Linee-guida per la gestione clinica della infezione/malattia da HCV nei pazienti con infezione da HIV
- Author
-
Antonucci, G., Antinori, A., Boumis, E., Longis, P., Gentile, M., Girardi, E., Lauria, F. N., Narciso, P., Noto, P., Palmieri, F., Oliva, A., nicola petrosillo, Rosati, S., Urso, R., Tocci, G., Tozzi, V., Comandini, U. V., and Ippolito, G.
41. First Italian Ebola virus disease case: Management of hospital internal and external communication
- Author
-
Salce, L., Barbato, S., Renna, D., Bianchini, F., Vaccaro, P., Mazzeo, F., Gasparini, A., Rizza, C., Lanfranchi, E., Petrosillo, N., Nicastri, E., Di Caro, A., Capobianchi, M. R., vincenzo puro, Ippolito, G., Bevilacqua, N., Boumis, E., Cicalini, S., Chinello, P., Corpolongo, A., Galati, V., Mariano, A., Rosati, S., Taglietti, F., Vincenzi, L., Antonini, M., Caravella, I., Garotto, G., Marchioni, L., Maritti, M., Biava, G., Rizzi, E. B., Castilletti, C., Bordi, L., Lalle, E., Meschi, S., Lapa, D., Marsella, P., Colavita, F., Chiappini, R., Mazzarelli, A., Quartu, S., Agrati, C., Carletti, F., Forbici, F., Valli, M. B., Abbate, I., Amendola, A., Garbuglia, A. R., Paglia, M. G., Bordi, E., Travaglini, D., Toffoletti, A., Battisti, G., Coppola, A., Marchis, L., Marco, N., Giacomini, P., Di Gianbattista, F., Guiducci, M., Marasco, A., Marzolini, A., Mercuri, A., Nieddu, P., Ondedei, S., Vescovo, M., Vitolo, L., Morea, M., Liguori, M., Lauria, F. N., Russo, A., D Aprile, P., Petrecchia, A., Gentile, M., Pittalis, S., Martini, L., Fusco, F. M., Lanini, S., Antinori, A., and Alberti, V. F.
42. Resection and Transplantation: Evaluation of Surgical Perspectives in HIV Positive Patients Affected by End-Stage Liver Disease
- Author
-
Ettorre, G. M., Vennarecci, G., Boschetto, A., Giovannelli, L., Antonini, M., Carboni, F., Santoro, R., Lepiane, P., Cosimelli, M., Lonardo, M. T., Del Nonno, F., Perracchio, L., Maritti, M., Moricca, P., D Offizi, G., Narciso, P., Noto, P., Boumis, E., nicola petrosillo, Visco, G., and Santoro, E.
- Subjects
Adult ,Carcinoma, Hepatocellular ,Liver Diseases ,Liver Neoplasms ,Humans ,HIV Infections ,Hepatitis B ,Hepatitis C ,Liver Transplantation - Abstract
The aim of this study was to evaluate the opportunity of surgical treatment in terms of liver resection or liver transplantation in HIV positive patients affected by an end stage liver disease that referred to our liver unit.Among 1350 outpatients who referred to our liver unit from January 2002 to September 2003, thirty-two (2,4%) were HIV positive. The routes of transmission of the viral infection, the related co-infections and the underlying liver disease were recorded. The therapeutic pathway was analysed. The kind and the duration of the surgical procedures were assessed.Fourteen (44%) of these thirty-two patients were not suitable for surgical treatment. Surgery was planned in 9 of 32 HIV positive patients (28%). Four patients (12%) were submitted to liver resection and OLT was performed in five patients (15%). Hepatocellular Carcinoma was present in 4 (44%) of the HIV positive patients considered for surgery.In conclusion in our centre the 28% of HIV positive out patients had the opportunity to receive a surgical treatment. The candidate to this surgery is mostly young, HCV and/or HBV coinfected and affected by HCC in 44% of cases.
43. Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients
- Author
-
Enrico Girardi, Antonucci, G., Ippolito, G., Raviglione, M. C., Rapiti, E., Perri, G. D., Babudieri, S., Almi, P., Angarano, G., Armignacco, O., Bevilacqua, N., Bini, A., Bottura, P., Boumis, E., Costigliola, P., Errante, I., Libanore, M., Liuzzi, G., Manzillo, E., Minoli, L., Narciso, P., Pagano, G., Pellizzer, G., Rusconi, S., Santoro, D., Savalli, E., Tavio, M., Traversa, A., and Viale, P.
44. Guidelines for the management of HCV infection in HIV-infected patients,Linee-guida per la gestione clinica della infezione/malattia da HCV nei pazienti con infezione da HIV
- Author
-
Antonucci, G., Antinori, A., Boumis, E., Longis, P., Gentile, M., Girardi, E., Lauria, F. N., Narciso, P., Noto, P., Fabrizio Palmieri, Oliva, A., Petrosillo, N., Rosati, S., Urso, R., Tocci, G., Tozzi, V., Comandini, U. V., and Ippolito, G.
45. Historical resistance profile helps to predict salvage failure
- Author
-
Zaccarelli M, Lorenzini P, Ceccherini-Silberstein F, Tozzi V, Federica Forbici, Gori C, Mp, Trotta, Boumis E, Narciso P, Cf, Perno, Antinori A, and Hiv, Collaborative Group For Clinical Use Of Genotype Resistance Test
46. Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients
- Author
-
Girardi, E., Antonucci, G., Ippolito, G., Raviglione, M.C., Rapiti, E., Diperri, G., Babudieri, S., Almi, P., Angarano, G., Armignacco, O., Bevilacqua, N., Bini, A., Bottura, P., Boumis, E., Costigliola, P., Errante, I., and Libanore, M.
- Subjects
Tuberculosis -- Risk factors ,HIV infection -- Complications - Abstract
Girardi, E.; Antonucci, G.; Ippolito, G.; Raviglione, M.C.; Rapiti, E.; Diperri, G.; Babudieri, S.; Almi, P.; Angarano, G.; Armignacco, O.; Bevilacqua, N.; Bini, A.; Bottura, P.; Boumis, E.; Costigliola, P.; [...]
- Published
- 1997
47. Prevention of side-effects of interferon.
- Author
-
Visco, G, Boumis, E, Noto, P, and Comandini, U V
- Subjects
- *
ANTI-inflammatory agents , *CHRONIC disease treatment , *HEPATITIS treatment , *INFLUENZA prevention , *STEROID drugs , *COMBINATION drug therapy , *CLINICAL trials , *COMPARATIVE studies , *DRUG administration , *INTERFERONS , *RESEARCH methodology , *MEDICAL cooperation , *PROTEINS , *RECOMBINANT proteins , *RESEARCH , *EVALUATION research , *RANDOMIZED controlled trials - Published
- 1991
- Full Text
- View/download PDF
48. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted in an Italian Reference Hospital
- Author
-
Annalisa Mondi, Patrizia Lorenzini, Concetta Castilletti, Roberta Gagliardini, Eleonora Lalle, Angela Corpolongo, Maria Beatrice Valli, Fabrizio Taglietti, Stefania Cicalini, Laura Loiacono, Francesco Di Gennaro, Gianpiero D’Offizi, Fabrizio Palmieri, Emanuele Nicastri, Chiara Agrati, Nicola Petrosillo, Giuseppe Ippolito, Francesco Vaia, Enrico Girardi, Maria Rosaria Capobianchi, Andrea Antinori, Sara Zito, Maria Alessandra Abbonizio, Amina Abdeddaim, Elisabetta Agostini, Fabrizio Albarello, Gioia Amadei, Alessandra Amendola, Maria Assunta Antonica, Mario Antonini, Tommaso Ascoli Bartoli, Francesco Baldini, Raffaella Barbaro, Barbara Bartolini, Rita Bellagamba, Martina Benigni, Nazario Bevilacqua, Gianluigi Biava, Michele Bibas, Licia Bordi, Veronica Bordoni, Evangelo Boumis, Marta Branca, Rosanna Buonomo, Donatella Busso, Marta Camici, Paolo Campioni, Flaminia Canichella, Alessandro Capone, Cinzia Caporale, Emanuela Caraffa, Ilaria Caravella, Fabrizio Carletti, Adriana Cataldo, Stefano Cerilli, Carlotta Cerva, Roberta Chiappini, Pierangelo Chinello, Maria Assunta Cianfarani, Carmine Ciaralli, Claudia Cimaglia, Nicola Cinicola, Veronica Ciotti, Francesca Colavita, Massimo Cristofaro, Salvatore Curiale, Alessandra D’Abramo, Cristina Dantimi, Alessia De Angelis, Giada De Angelis, Maria Grazia De Palo, Federico De Zottis, Virginia Di Bari, Rachele Di Lorenzo, Federica Di Stefano, Davide Donno, Francesca Evangelista, Francesca Faraglia, Anna Farina, Federica Ferraro, Lorena Fiorentini, Andrea Frustaci, Matteo Fusetti, Vincenzo Galati, Paola Gallì, Gabriele Garotto, Ilaria Gaviano, Saba Gebremeskel Tekle, Maria Letizia Giancola, Filippo Giansante, Emanuela Giombini, Guido Granata, Maria Cristina Greci, Elisabetta Grilli, Susanna Grisetti, Gina Gualano, Fabio Iacomi, Marta Iaconi, Giuseppina Iannicelli, Carlo Inversi, Maria Elena Lamanna, Simone Lanini, Daniele Lapa, Luciana Lepore, Raffaella Libertone, Raffaella Lionetti, Giuseppina Liuzzi, Andrea Lucia, Franco Lufrani, Manuela Macchione, Gaetano Maffongelli, Alessandra Marani, Luisa Marchioni, Andrea Mariano, Maria Cristina Marini, Micaela Maritti, Annelisa Mastrobattista, Ilaria Mastrorosa, Giulia Matusali, Valentina Mazzotta, Paola Mencarini, Silvia Meschi, Francesco Messina, Sibiana Micarelli, Giulia Mogavero, Marzia Montalbano, Chiara Montaldo, Silvia Mosti, Silvia Murachelli, Maria Musso, Michela Nardi, Assunta Navarra, Martina Nocioni, Pasquale Noto, Roberto Noto, Alessandra Oliva, Ilaria Onnis, Sandrine Ottou, Claudia Palazzolo, Emanuele Pallini, Giulio Palombi, Carlo Pareo, Virgilio Passeri, Federico Pelliccioni, Giovanna Penna, Antonella Petrecchia, Ada Petrone, Elisa Pianura, Carmela Pinnetti, Maria Pisciotta, Pierluca Piselli, Silvia Pittalis, Agostina Pontarelli, Costanza Proietti, Vincenzo Puro, Paolo Migliorisi Ramazzini, Alessia Rianda, Gabriele Rinonapoli, Silvia Rosati, Dorotea Rubino, Martina Rueca, Alberto Ruggeri, Alessandra Sacchi, Alessandro Sampaolesi, Francesco Sanasi, Carmen Santagata, Alessandra Scarabello, Silvana Scarcia, Vincenzo Schininà, Paola Scognamiglio, Laura Scorzolini, Giulia Stazi, Giacomo Strano, Chiara Taibi, Giorgia Taloni, Tetaj Nardi, Roberto Tonnarini, Simone Topino, Martina Tozzi, Francesco Vairo, Alessandra Vergori, Laura Vincenzi, Ubaldo Visco-Comandini, Serena Vita, Pietro Vittozzi, Mauro Zaccarelli, Antonella Zanetti, Mondi, A., Lorenzini, P., Castilletti, C., Gagliardini, R., Lalle, E., Corpolongo, A., Valli, M. B., Taglietti, F., Cicalini, S., Loiacono, L., Di Gennaro, F., D'Offizi, G., Palmieri, F., Nicastri, E., Agrati, C., Petrosillo, N., Ippolito, G., Vaia, F., Girardi, E., Capobianchi, M. R., Antinori, A., Zito, S., Abbonizio, M. A., Abdeddaim, A., Agostini, E., Albarello, F., Amadei, G., Amendola, A., Antonica, M. A., Antonini, M., Bartoli, T. A., Baldini, F., Barbaro, R., Bartolini, B., Bellagamba, R., Benigni, M., Bevilacqua, N., Biava, G., Bibas, M., Bordi, L., Bordoni, V., Boumis, E., Branca, M., Buonomo, R., Busso, D., Camici, M., Campioni, P., Canichella, F., Capone, A., Caporale, C., Caraffa, E., Caravella, I., Carletti, F., Cataldo, A., Cerilli, S., Cerva, C., Chiappini, R., Chinello, P., Cianfarani, M. A., Ciaralli, C., Cimaglia, C., Cinicola, N., Ciotti, V., Colavita, F., Cristofaro, M., Curiale, S., D'Abramo, A., Dantimi, C., De Angelis, A., De Angelis, G., De Palo, M. G., De Zottis, F., Di Bari, V., Di Lorenzo, R., Di Stefano, F., Donno, D., Evangelista, F., Faraglia, F., Farina, A., Ferraro, F., Fiorentini, L., Frustaci, A., Fusetti, M., Galati, V., Galli, P., Garotto, G., Gaviano, I., Tekle, S. G., Giancola, M. L., Giansante, F., Giombini, E., Granata, G., Greci, M. C., Grilli, E., Grisetti, S., Gualano, G., Iacomi, F., Iaconi, M., Iannicelli, G., Inversi, C., Lamanna, M. E., Lanini, S., Lapa, D., Lepore, L., Libertone, R., Lionetti, R., Liuzzi, G., Lucia, A., Lufrani, F., Macchione, M., Maffongelli, G., Marani, A., Marchioni, L., Mariano, A., Marini, M. C., Maritti, M., Mastrobattista, A., Mastrorosa, I., Matusali, G., Mazzotta, V., Mencarini, P., Meschi, S., Messina, F., Micarelli, S., Mogavero, G., Montalbano, M., Montaldo, C., Mosti, S., Murachelli, S., Musso, M., Nardi, M., Navarra, A., Nocioni, M., Noto, P., Noto, R., Oliva, A., Onnis, I., Ottou, S., Palazzolo, C., Pallini, E., Palombi, G., Pareo, C., Passeri, V., Pelliccioni, F., Penna, G., Petrecchia, A., Petrone, A., Pianura, E., Pinnetti, C., Pisciotta, M., Piselli, P., Pittalis, S., Pontarelli, A., Proietti, C., Puro, V., Ramazzini, P. M., Rianda, A., Rinonapoli, G., Rosati, S., Rubino, D., Rueca, M., Ruggeri, A., Sacchi, A., Sampaolesi, A., Sanasi, F., Santagata, C., Scarabello, A., Scarcia, S., Schinina, V., Scognamiglio, P., Scorzolini, L., Stazi, G., Strano, G., Taibi, C., Taloni, G., Nardi, T., Tonnarini, R., Topino, S., Tozzi, M., Vairo, F., Vergori, A., Vincenzi, L., Visco-Comandini, U., Vita, S., Vittozzi, P., Zaccarelli, M., and Zanetti, A.
- Subjects
Male ,0301 basic medicine ,Time Factors ,medicine.medical_treatment ,Respiratory System ,coronavirus ,Infectious and parasitic diseases ,RC109-216 ,Severity of Illness Index ,Cohort Studies ,0302 clinical medicine ,risk factors ,030212 general & internal medicine ,Respiratory disease ,General Medicine ,Middle Aged ,Virus Shedding ,Infectious Diseases ,symbols ,RNA, Viral ,Female ,Coronavirus ,COVID-19, viral clearance, viral shedding ,Risk factors ,SARS-CoV-2 ,Cohort study ,Adult ,Microbiology (medical) ,medicine.medical_specialty ,viral shedding ,Coronaviru ,030106 microbiology ,Article ,NO ,03 medical and health sciences ,symbols.namesake ,Internal medicine ,Severity of illness ,medicine ,Humans ,Poisson regression ,Aged ,Proportional Hazards Models ,Mechanical ventilation ,business.industry ,Proportional hazards model ,COVID-19 ,Retrospective cohort study ,medicine.disease ,Respiratory failure ,Risk factor ,business ,viral clearance - Abstract
Background Few data about predictors and outcomes associated with prolonged SARS-CoV-2 RNA shedding (VS) are available. Methods Retrospective study including all patients admitted with COVID-19 in an Italian reference hospital for infectious diseases between March 1 and July 1, 2020. Predictors of viral clearance (VC) and prolonged VS from upper respiratory tract were assessed by Poisson regression and logistic regression analyses. The causal relation between duration of VS and probability of clinical outcomes was evaluated through inverse probability weighted Cox model. Results 536 subjects were included. Median duration of VS from symptoms onset was 18 days (IQR 12-26). The estimated 30-day probability of VC was 70.2% (95%CI:65-75). At multivariable analysis, patients with comorbidities (aIRR = 0.88, p = 0.004), lymphopenia at hospital admission (aIRR = 0.75, p = 0.032) and with moderate/severe respiratory disease (aIRR = 0.42, p 1000 ng/mL at admission (aOR = 1.76, p = 0.035) independently predicted prolonged VS. The achievement of VC doubled the chance of clinical recovery (aHR = 2.17, p
- Published
- 2021
49. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
- Author
-
Ivan Gentile, Jesús Rodríguez-Baño, Alia Eworo, Gloria Taliani, E. Nadal, M. Valerio, A. Beteta-Lopez, Christoph Schramm, Pierluigi Viale, Bruno Baršić, Cristina Badia, S. Ludovisi, Alberto Enrico Maraolo, Gabriella Verucchi, Elena Seminari, M. de Cueto, Maddalena Giannella, E. Boumis, S. Grieco, Pilar Retamar, Nazaret Cobos-Trigueros, Caterina Campoli, Emilio Bouza, Mauro Bernardi, Patrizia Burra, M. Varguvic, Sara K. Tedeschi, Esther Calbo, María Dolores González-Ripoll Navarro, N. Bar Sinai, Mario Venditti, Andreas Stallmach, Russell E. Lewis, Guglielmo Borgia, Patricia Muñoz, Antonio Riccardo Buonomo, Mical Paul, Gianpiero D'Offizi, Michele Bartoletti, Paolo Caraceni, M.A. Galan-Ladero, Mario Tumbarello, Manuela Merli, Marco Senzolo, G. Siccardi, R. Losito, A. Ottobrelli, E. Lopez Cortes, A. Rianda, Cristina Lucidi, Simone Ambretti, Nicola Petrosillo, M. Torrani Cerenzia, Tony Bruns, Bartoletti, M., Giannella, M., Lewis, R., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M, Cobos-Trigueros, N., Seminari, E., Retamar, P., Muñoz, P., Tumbarello, M., Burra, P., Torrani Cerenzia, M., Barsic, B., Calbo, E., Maraolo, A.E., Petrosillo, N., Galan-Ladero, M.A., D'Offizi, G., Bar Sinai, N., Rodríguez-Baño, J., Verucchi, G., Bernardi, M., Viale, P., Bartoletti, M, Giannella, M, Lewis, R, Caraceni, P, Tedeschi, S, Paul, M, Schramm, C, Bruns, T, Cobos-trigueros, N, Seminari, E, Retamar, P, Muñoz, P, Tumbarello, M, Burra, P, Torrani Cerenzia, M, Barsic, B, Calbo, E, Maraolo, Ae, Petrosillo, N, Galan-ladero, Ma, D'Offizi, G, Bar Sinai, N, Rodríguez-baño, J, Verucchi, G, Bernardi, M, Viale, P, Campoli, C, Siccardi, G, Ambretti, S, Stallmach, A, Venditti, M, Lucidi, C, Ludovisi, S, De Cueto, M, Navarro, Md, Lopez Cortes, E, Bouza, E, Valerio, M, Eworo, A, Losito, R, Senzolo, M, Nadal, E, Ottobrelli, A, Varguvic, M, Badia, C, Borgia, G, Gentile, I, Buonomo, Ar, Boumis, E, Beteta-lopez, A, Rianda, A, Taliani, G, and Grieco, S.
- Subjects
Liver Cirrhosis ,Male ,Microbiology (medical) ,medicine.medical_specialty ,Multidrug-resistant pathogen ,Comorbidity ,Bloodstream infection ,Bacterial infections ,Bloodstream infections ,CLIF-SOFA ,Multidrug-resistant pathogens ,Logistic regression ,Liver cirrhosi ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Sepsis ,Internal medicine ,Epidemiology ,medicine ,Humans ,Prospective Studies ,030212 general & internal medicine ,Mortality ,Risk factor ,Intensive care medicine ,Prospective cohort study ,Aged ,Proportional hazards model ,business.industry ,Liver cirrhosis ,Infectious Diseases ,Mortality rate ,Hazard ratio ,Disease Management ,Drug Resistance, Microbial ,General Medicine ,Middle Aged ,Prognosis ,Patient Outcome Assessment ,Population Surveillance ,Female ,030211 gastroenterology & hepatology ,Bacterial infection ,business ,Cohort study - Abstract
ESGBIS/BICHROME Study Group: C. Campoli, G. Siccardi, S. Ambretti, A. Stallmach, M. Venditti, C. Lucidi, S. Ludovisi, M. De Cueto, M. D. Navarro, E. Lopez Cortes, E. Bouza, M. Valerio, A. Eworo, R. Losito, M. Senzolo, E. Nadal, A. Ottobrelli, M. Varguvic, C. Badia, G. Borgia, I. Gentile, A. R. Buonomo, E. Boumis, A. Beteta-Lopez, A. Rianda, G. Taliani, S. Grieco., [Objectives] To describe the current epidemiology of bloodstream infection (BSI) in patients with cirrhosis; and to analyse predictors of 30-day mortality and risk factors for antibiotic resistance., [Methods] Cirrhotic patients developing a BSI episode were prospectively included at 19 centres in five countries from September 2014 to December 2015. The discrimination of mortality risk scores for 30-day mortality were compared by area under the receiver operator risk and Cox regression models. Risk factors for multidrug-resistant organisms (MDRO) were assessed with a logistic regression model., [Results] We enrolled 312 patients. Gram-negative bacteria, Gram-positive bacteria and Candida spp. were the cause of BSI episodes in 53%, 47% and 7% of cases, respectively. The 30-day mortality rate was 25% and was best predicted by the Sequential Organ Failure Assessment (SOFA) and Chronic Liver Failure–SOFA (CLIF-SOFA) score. In a Cox regression model, delayed (>24 hours) antibiotic treatment (hazard ratio (HR) 7.58; 95% confidence interval (CI) 3.29–18.67; p < 0.001), inadequate empirical therapy (HR 3.14; 95% CI 1.93–5.12; p < 0.001) and CLIF-SOFA score (HR 1.35; 95% CI 1.28–1.43; p < 0.001) were independently associated with 30-day mortality. Independent risk factors for MDRO (31% of BSIs) were previous antimicrobial exposure (odds ratio (OR) 2.91; 95% CI 1.73–4.88; p < 0.001) and previous invasive procedures (OR 2.51; 95% CI 1.48–4.24; p 0.001), whereas spontaneous bacterial peritonitis as BSI source was associated with a lower odds of MDRO (OR 0.30; 95% CI 0.12–0.73; p 0.008)., [Conclusions] MDRO account for nearly one-third of BSI in cirrhotic patients, often resulting in delayed or inadequate empirical antimicrobial therapy and increased mortality rates. Our data suggest that improved prevention and treatment strategies for MDRO are urgently needed in the liver cirrhosis patients.
- Published
- 2018
50. Changing patterns in the etiology of HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy
- Author
-
G De Carli, Paolo Visca, Nicola Petrosillo, Giuseppe Ippolito, Evangelo Boumis, Enrico Girardi, Orlando Armignacco, Boumis, E, Petrosillo, N, Girardi, E, De Carli, G, Armignacco, O, Visca, Paolo, and Ippolito, G.
- Subjects
Microbiology (medical) ,Adult ,Male ,HIV Infections ,medicine.disease_cause ,Haemophilus influenzae ,Antiretroviral Therapy, Highly Active ,Streptococcus pneumoniae ,Pneumonia, Bacterial ,Medicine ,Humans ,Retrospective Studies ,business.industry ,Pseudomonas aeruginosa ,Sulfamethoxazole ,Respiratory disease ,Bacterial pneumonia ,virus diseases ,General Medicine ,Middle Aged ,medicine.disease ,Trimethoprim ,Community-Acquired Infections ,Pneumonia ,Infectious Diseases ,Immunology ,Female ,business ,medicine.drug - Abstract
Bacterial pneumonia is the most prevalent and serious HIV-associated bacterial infection [1]. The most common etiologic agents of community-acquired bacterial pneumonia (CABP) are similar in HIV-infected and uninfected subjects, mainly Streptococcus pneumoniae and Haemophilus influenzae [1, 2]. However, an increasing prevalence of Pseudomonas aeruginosa [3-5] and trimethoprim-sulfamethoxazole (TMP-SMX)-resistant organisms [5] has been observed in severely immunosuppressed HIV-infected patients.
- Published
- 2001
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.